Preprint
Review

This version is not peer-reviewed.

Botany, Ethnopharmacology, Phytochemistry, Biological Activities of Acmella oleracea: A Comprehensive Review

Submitted:

16 January 2026

Posted:

19 January 2026

You are already at the latest version

Abstract
Acmella oleracea (L.) R. K. Jansen (Asteraceae), commonly known as the "toothache plant" or "jambu," is a significant medicinal plant that has been traditionally used in Brazil and other tropical and subtropical regions for relieving dental pain, as an anti-inflammatory agent, and as a culinary spice. Due to its versatile utility, this plant has been extensively studied in modern medicine and pharmacy for its diverse pharmacological properties, including anesthetic, analgesic, anti-inflammatory, antioxidant, and antimicrobial activities. Analytical research on the chemical compositions responsible for these activities has led to the identification of approximately 120 secondary metabolites. These findings provide scientific validation for its traditional uses and have spurred research into the development of ingredients for functional foods and cosmetics. This review incorporates the latest research findings, focusing on biological activities and compounds that have been practically isolated or can be isolated based on quantitative experimental data, to serve as a practical reference for industrial development. Furthermore, factors influencing the content of alkylamides and phenolic compounds, two major bioactive groups, are summarized to support material development. Ultimately, this review aims to provide a clearer understanding of the plant’s utility and contribute to the development of products that enhance human health.
Keywords: 
;  ;  ;  ;  

1. Introduction

Acmella oleracea (L.) R. K. Jansen (A. oleracea), a member of the Asteraceae family, is an annual herb characterized by its yellow-to-red cylindrical discoid capitula. Due to the distinct appearance of its central discoid, which turns red, it is commonly referred to by various names such as eyeball plant, spot flower, and buzz button (Figure 1). More notably, it is widely known as the "toothache plant" owing to its exceptional ethnomedicinal efficacy in relieving dental pain. It is also called "paracress," a term derived from the Para region of Brazil, its place of origin, meaning "cress-like vegetable." [1,2]. Beyond its use for toothaches, A. oleracea has been traditionally utilized for a diverse range of medicinal purposes. Various parts of the plant have been employed to treat wounds, stomachaches, skin diseases, and muscular pain, or served as laxatives, anthelmintics, and appetite enhancers [3]. Reflecting these broad ethnopharmacological applications, extensive modern scientific research has been conducted on its pharmacological activities, including anti-inflammatory, antioxidant, analgesic, anesthetic, antiplasmodial, antibacterial, wound healing, and antipyretic effects. In addition to academic interest, there is active research into its development as functional health foods. In particular, spilanthol, the representative bioactive compound of this species, has seen a significant increase in patent registrations for technological development. Its applications are being widely explored in oral care products, personal care items, detergents, and the food and beverage industry [4]. Consequently, A. oleracea remains a botanical resource with substantial potential for further exploration. To facilitate effective research and industrial application, a systematic consolidation of existing research findings is highly warranted. Unlike previous reviews that focused primarily on specific chemical classes or the entire Acmella genus, this review aims to provide the most up-to-date and comprehensive analysis of the phytochemical and pharmacological profiles specifically for A. oleracea. In terms of phytochemical reporting, we did not include all compounds simply based on their detection; rather, we comprehensively summarized compounds that have been directly isolated or reported with quantitative data in articles, ensuring the information is robust enough for actual industrial development. To achieve these objectives, a literature search was conducted across PubMed/MedLine, Science Direct, and Google Scholar. The search and data collection were performed using the primary keyword "Acmella oleracea," along with "Spilanthes acmella"—a term frequently misused by many researchers—as well as "Phytochemical" and "Activities/effects." This review involved a thorough assessment of reported doses (and administration routes), experimental models, and outcomes. Additionally, it scrutinized the plausible mechanisms of action associated with A. oleracea and its primary bioactive compounds.

2. Botany

The genus Acmella, a member of Asteraceae (conserved name, Compositae), embraces 30 species and 9 additional infraspecific taxa dispersed in tropical and subtropical areas [5] (Table 1). Since the genus shows extremely complicated patterns in morphological and chromosomal perspective, it has been very difficult to demarcate the taxa and often misapplied in either description or illustration [6]. Although there has been reclassification and restoration of the taxonomical position of the genus Acmella by means of cladistic and chromosomal studies [5], it is sometimes mentioned interchangeably with the genus Spilanthes even from recently published papers. A. oleracea, the most distinguished and recognized species for its medicinal purpose, is sometimes described as identical to Spilanthes acmella (L.) Murr. which officially accepted name is Blainvillea acmella (L.) Philipson [5, World Flora Online, 2025].
Although its native habitat is unclear, many reported that it was originated from Amazonian countries in South America such as Peru and Brazil as majority opinion [1,7]. Jansen suggested that A. oleracea was highly likely cultivated from A. alba, a wild plant in Peru [5]. From theses countries, it has been introduced to and subsequently cultivated in many tropical and subtropical regions such as North America, Africa, Southeast Asia, India and China which is supported by its various vernacular names from many different countries [1,8,9] (Figure 2).
As an annual herb, the height of A. oleracea reaches up to 20–90 cm high and its stems are commonly decumbent or erect, but burly, branched and glabrous with green to red. Petioles are 2–6.5 in length and glabrous or barely pilose, and has winged stipules in its base [1,5]. For leaves, the shape of leaf blade is generally broadly ovate with acute apex, that of margin is dentate, with 5–10 cm and 4–8 cm for length and width, respectively. Both surfaces of leaf are hairless, and its base truncates or shortly attenuates. Inflorescence is solitary, but sometimes axillary. The capitula (a dense cluster of many small flowers), the most distinct feature of A. oleracea, is cylindrical discoid-shaped with 10.5–23.5 mm, 11–17 mm in height and diameter, respectively [1,5]. Moreover, the color is featured golden-yellow with a prominent dark red center. Since it resembles an eye, one of its nickname is eyeball plant. The peduncles, a small stalk that joins the flower to the main stem, is glabrous or barely hairy with 3.5–12.5 mm in length [1,5] (Figure 1).

3. Traditional Uses

As previously described in the botany section, A. oleracea believed to have originated in Peru or Brazil has been introduced and utilized in numerous countries worldwide due to its ease of cultivation and diverse therapeutic properties. Its primary applications are categorized into medicinal and culinary uses, while it also serves minor roles in tribal religious rituals and as an ornamental plant [10,11].

3.1. Medicinal Purpose

The most prominent global medicinal application of A. oleracea is for the relief of toothache and as a local anesthetic. For instance, among the Irula tribe in the Hasanur Hills of Tamil Nadu, India, where the plant is locally known as "Mandal Poo Chedi," the flowers are crushed and applied directly to the affected site [12]. This extensive use for treating toothache, throat and gum infections across the Americas, Asia, and Africa has earned the species its well-known nickname, the "toothache plant" [12,13,14].
In Brazil, the plant is commonly referred to as "jambu" and has been traditionally used by inhabitants of the Amazon basin to treat tuberculosis. In India, specifically in the Chhindwara district of Madhya Pradesh, a paste made from the roots is employed to treat various throat problems [15]. Furthermore, the flowers are recognized for their sialogogue effect (inducing salivation), which is utilized to alleviate xerostomia and aid digestion—an effect primarily attributed to the presence of spilanthol [16]. In some cultures, flowers are also used to treat stammering in children [17].
Regional variations in the medicinal application of A. oleracea are diverse and culturally specific. In the Bogra district of Bangladesh, the plant is locally referred to as "Vhadalika," where its leaves and flowers are traditionally employed to treat leucorrhea in women [18]. Similarly, in the Chittagong Hill Tracts of Bangladesh, it is known as "Jhummosak," and a paste derived from the entire plant is utilized as a remedy for poisonous stings [19]. In Cameroon, the species serves a dual purpose as a treatment for snakebites and a remedy for articular rheumatism [20]. Besides these, the roots of the plant have been utilized as a purgative to relieve constipation and the whole herb to facilitate the expulsion of urinary calculi (urolithiasis) and to treat conditions such as scurvy and various digestive disorders [21].

3.2. Culinary Uses

Thanks not only to Beyond its medicinal value, but also to the unique tingling and pungent sensations they produce, the leaves and flowers of A. oleracea are integral to various culinary traditions. The culinary applications of A. oleracea are geographically diverse and reflect the plant’s unique sensory profile. In the United States, the raw leaves are utilized as a pungent flavoring agent in salads [22], whereas in India, they are typically prepared as a cooked vegetable for inclusion in soups and meat dishes[5,23]. In Brazil, both fresh and cooked leaves serve as staple ingredients in indigenous cuisine, particularly within the provinces of Acre, Amazonas, Pará, and Ceará [24]. Culinary traditions in Southeast Asia also incorporate the plant; in Java, Indonesia, young shoots and leaves are served raw as 'lalab' accompanied by sambal, while in Thailand, both the leaves and flower heads are integrated into various curries [25,26]. Furthermore, in Japan, the flowers are valued as a food spice and are also employed as a flavoring agent in dentifrices [27].
The flower buds, commercially known as "Buzz Buttons," "Szechuan Buttons," or "Electric Buttons," are often used to offset the intense heat of chilies [24,28]. Ingesting a whole bud results in an initial grassy flavor, followed by an intense numbing sensation, excessive salivation, and a cooling effect in the throat. Notable modern culinary applications include Szechuan Button-infused eel dishes, cocktails, and sorbets [24,28]. In India, the buds and their oleoresins are also used to flavor chewing tobacco. Related information is summarized in Table 2.

4. Phytochemistry

Due to the obvious and various activities of A. oleracea, phytochemical composition of the plant has been extensively studied. Some GC/MS based chemical studies have reported that A. oleracea is rich in essential oil comprising about 15% of the constituents among which alkylamides (122), monoterpenoids (2328), sesquiterpenoids (2937) are present dominantly [32,33]. Also, some other terpenoids such as a diterpene (38) and triterpenes (3943), and some lipophilic constituents such as steroids (6063) and hydrocarbon derivative (6472) also have been reported from the plant [31]. Not only these lipophilic parts, but also hydrophilic fractions began to attract attention because of activity guided isolation. As opposed to inflorescences, leaves and root are rich in phenolic compounds (4456, 59) and flavonoids (57, 58) [34,35]. Major second metabolites which have been isolated or identified with high abundance from various studies are summarized in Table 3.

4.1. N-Alkylamides

N-Alkylamides (NAAs) are characterized by a molecular structure centered around an amide bond, flanked by a fatty acid chain on one side and a residual amino acid moiety on the other. As expected from the structure, it is biologically synthesized by condensation reaction of fatty acid chain (unsaturated in most cases) and amin moiety derived from amino acid through decarboxylation [36]. Through the numerous combinations of 200 fatty acids and 23 amines, more than 300 NAAs have been reported from totally 25 plant families, mainly eight (Asteraceae, Piperaceae, Rutaceae, Brassicaceae, Euphorbiaceae, Aristolochiaceae, Menispermaceae, and Poaceae) [37,38]. Though some families such as Convolvulaceae, Euphorbiaceae, Menispermaceae, and Rutaceae show the biosynthesis of NAAs featuring aliphatic moieties in both their amine and acid components as a prominent metabolic characteristic, they also produce other major types of secondary metabolites including alkaloid [38]. On the other hand, several genera in Asteraceae such as Acmella, Spilanthes, Echinacea and Heliopsis, dominantly produce NAAs as major metabolites, granting its characteristics [39]. As NAAs containing plants generally exhibit pungent taste, numbness and tingling sensation [35], NAAs, especially, spilanthol (also called affinin) which is one of the most famous NAAs in Asteraceae, became the reason for many vernacular names of A. oleracea such as ‘toothache plant, brede mafane’ which means hot taste grass in Malagacy [35,40]. NAAs from the Acmella genus are normally composed of N-isobutyl, N-methylbutyl or N-phenethylamine for amine part and medium-chain residues (C8 to C13) for fatty acid [39]. Among 70 NAAs identified from Acmella and Spilanthes species [36], 22 NAAs (122) have been isolated or identified with moderate or large amounts enough to be isolated from A. oleracea and many of them are N-isobutylamides (116), followed by N-phenethylamides (1922) and N-methylbutylamides (17 and 18) in the order of frequency.
Since many biological activities were known to be ascribed to NAAs, there have been various research on development of efficient extraction methods or quantification for NAAs, especially, spilanthol (6) for industrial purposes. As NAAs are normally amphiphilic due to the relatively polar amide and lipophilic acyl chain residue easily expected from the structure, a wide range of solvents such as methanol, ethanol, n-hexane, ethyl acetate, or even CO2 for superciritical extraction have been used [33,41,42,43,44]. Ferrara reported that NAAs are accumulated five times more in aerial parts (2.77 mg/g, DE) than root (0.49 mg/g, DE) and for spilanthol (6), ten times more concentrated in aerial parts (2.20 mg/g, DE) than root (0.22 mg/g, DE), which is also supported by reports on isolation of NAAs (Table 3). When limited to aerial parts, NAAs in flower and leave part are similar as 7.69% and 8.42%, respectively, which are twice as much than that in stem (3.09%) [45]. Meanwhile, the content of spilanthol (6) was extremely high in flower part (16.50 mg/g, DW) than those in leave (0.34 mg/g) and stem part (0.24 mg/g) in accelerated solvent extraction method. In a separate study, Dias showed that yield of spilanthol (6) in flower, leave and stem were 65.4, 19.7 and 47.3%, respective, by means of supercritical fluid extracted coupled enhanced solvent extraction (SFE-ESE) method, demonstrating that low content of spilanthol (6) in leave and stem part could be improved to some extent depending on extraction method [44]. In case of optimization for extraction solvent, Kavallieratos evaluated extraction efficiency of various solvent (n-hexane, ethanol, methanol, dichloromethane, petroleum ether, ethyl acetate) for spilanthol (6) contents by using sonication and concluded that n-hexane extract showed the most concentrated content of spilanthol (20.9 g/100 g, dry extract) followed by petroleum ether (19.7), dichloromethane (17.7), ethyl acetate (16.5), methanol (15.9), ethanol (11.4) but, methanol extract exhibited largest absolute amount (1.3 g/100 g, dry biomass), followed by dichloromethane (0.9), ethyl acetate (0.7), n-hexane (0.6), ethanol (0.4), petroleum ether (0.4) [42]. Meanwhile, another research reported that absolute amounts of spilanthol (6) in defatted 80% ethanol fraction and n-hexane fraction were similar after consideration of concentration and extraction yield in in vitro seedling [35].
For the quantitative analysis of major NAAs, spilanthol has highest proportion in flower, while it was contained in medium or small amount when limited to leave part, though it is the most abundant NAAs in whole aerial part [33,42,46]. Besides spilanthol (6), (2E,6Z,8E)-N-(2-methylbutyl)-2,6,8-decatrienamide (homospilanthol) (17), (2E,7Z)-N-isobutyl-2,7-decadienamide (3), (2E)-N-isobutyl-2-undecene-8,10-diynamide (9), (2E,7Z)-N-isobutyl-2,7-tridecadiene-10,12-diynamide (16), (2E)-N-(2-methylbutyl)-2-undecene-8,10-diynamide (18) have been reported in medium or small but enough to be isolated in whole aerial part [33,40,42,46]. Interestingly, there was attempt to develop for optimized extraction method maximizing the content of spilanthol in essential oil, reporting microwave-assisted extraction showed around 6 times higher yield (13.31 g/100 g in EO) than that of hydrodistillation (2.24). In most cases, fatty acid moiety in NAAs is unsaturated so it is vulnerable to sunlight and easy to be degraded. Bearing in mind that deleterious effect on usefulness of A. oleracea, savic reported conducted will-timed research on stability of main NAA in commercially purchasable products. Photostability of 1, 6, 9, 11, 16, 17, 18, 19 and 21 in hydroglycolic extract of A. oleracea suspended in various solvents (methanol, ethanol, saline, water) were evaluated in 30 min intervals up to 120 min. As a result, (2E,6Z,8E)-N-(2-methylbutyl)-2,6,8-decatrienamide (homospilanthol) (17) and spilanthol (6) turned out to be the most stable NAAs in order. Also, in methanol, there were no significant differences in stability among compounds throughout time, whereas in other solvents, stability decreased significantly in the order of ethanol, saline, and water [47]. 4 and 5 were suggested as degraded form of spilanthol (6). The research findings regarding the contents of spilanthol and NAAs according to various factors such as plant parts, extraction methods, and solvents are summarized in Table 4.
Figure 3. Structures of N-alkylamides in A. oleracea.
Figure 3. Structures of N-alkylamides in A. oleracea.
Preprints 194608 g003
Table 3. Summary of the isolated or identified with medium to large amount from A. oleracea.
Table 3. Summary of the isolated or identified with medium to large amount from A. oleracea.
Compound Formula Part Extraction Identification Remark Ref.
Alkylamide
(2Z)-N-isobutyl-2-nonene-6,8-diynamide (1) C13H17NO F MeOH ex. HPLC, ESI-IT-TOF-MS, NMR 20 mg [48]
(2E)-N-isobutyl-2-decamonoenamide (2) C14H27NO AP, R 80% EtOH ex., sonication HPLC-DAD-ESI-MS From in vitro seedlings [41,49]
(2E,7Z)-N-isobutyl-2,7-decadienamide (3) C14H25NO AP 80% EtOH ex., sonication HPLC-DAD-ESI-MS From in vitro seedlings [35]
(2E,6Z)-N-isobutyl-8,9-dihydroxy-2,6-decadienamide (4) C14H25NO3 L EtOH ex., CH2Cl2 fr. NMR 15 mg of mixture with 3 out of 0.8 kg raw material [50]
(2E,7E)-N-isobutyl-6,9-dihydroxy-2,7-decadienamide (5) C14H25NO3 L EtOH ex., CH2Cl2 fr. NMR 15 mg out of 0.8 kg raw material [50]
(2E,6Z,8E)-N-isobutyl-2,6,8-decatrienamide (spilanthol) (6) C14H23NO F n-Hexane ex. GC-MS, NMR 135 mg out of 1.5 kg raw material [51]
F, L, S SFE GC-FID 65.4%(flower), 19.7%(leave), 47.3%(stem) of dry weight [44]
(2Z)-N-isobutyl-2-decene-6,8-diynamide (7) C14H19NO R Petrol:Et2O(1:1) HPLC, HR-MS, NMR 1 mg out of 50 g of raw material [52]
(2E,7Z,9E)-N-isobutyl-2,7,9-undecatrienamide (8) C15H25NO F n-Hexane ex. GC-MS, NMR 135 mg out of 1.5 kg [51]
(2E)-N-isobutyl-2-undecene-8,10-diynamide (9) C15H21NO F n-Hexane ex. NMR 5 mg out of 1.5 kg [51]
(2E,4Z,8Z,10E)-N-isobutyl-2,4,8,10-dodecatetraenamide (10) C16H25NO A n-Hexane ex., soxhlet GC-MS 67% of relative abundance [9]
(2E,4Z)-N-isobutyl-2,4-undecadiene-8,10-diynamide (11) C15H19NO L EtOH ex. HPLC-ESI-MS/MS 15.8% of relative abundance [46]
(2E,5Z)-N-isobutyl-2,5-undecadiene-8,10-diynamide (12) C15H19NO F 95% EtOH ex., EtOAc fr. NMR, HR-ESI-MS 2.5 mg out of 4.5 kg of raw material [53]
(2E,4E,8Z,10E)-N-isobutyl-2,4,8,10-dodecatetraenamide (13) C16H25NO AP 95% EtOH ex. NMR, Q-TOF-MS 10 mg out of 1.5 kg of raw material [54]
(2E,4E,8Z,10Z)-N-isobutyl-2,4,8,10-dodecatetraenamide (14) C16H25NO L EtOH ex. HPLC-ESI-MS/MS 38.0% of relative abundance [46]
(7Z)-N-isobutyl-7-tridecene-10,12-diynamide (15) C17H25NO F n-Hexane ex. HPLC, HR-MS 5 mg out of 200 g of n-hex ex. [55]
(2E,7Z)-N-isobutyl-2,7-tridecadiene-10,12-diynamide (16) C17H23NO F n-Hexane ex. HPLC, HR-MS 5 mg out of 200 g of n-hex ex. [55]
(2E,6Z,8E)-N-(2-methylbutyl)-2,6,8-decatrienamide (homospilanthol) (17) C15H25NO F, L EtOH ex. HPLC-ESI-MS/MS 7.9%(flower) and 12.7%(leave) of relative abundance [46]
(2E)-N-(2-methylbutyl)-2-undecene-8,10-diynamide (18) C16H23NO F n-Hexane ex. HPLC, HR-MS 10 mg out of 200 g of n-hex ex. [55]
N-phenethyl-2,3-epoxy-6,8-nonadiynamide (19) C17H17NO2 AP Propanediol/water UHPLC-DAD-ESI-MS/MS [47]
N-phenethyl-2,3-dihydroxy-6,8-nonadiynamide (20) C17H19NO3 L EtOH ex., CH2Cl2 fr. NMR 10 mg out of 0.8 kg raw material [50]
(2Z)-N-phenethyl-2-nonene-6,8-diynamide (21) C17H17NO L EtOH ex. HPLC-ESI-MS/MS 15.5% of relative abundance [46]
(2Z)-N-phenethyl-2-decene-6,8-diyamide (22) C18H19NO L EtOH ex., n-hexane fr. NMR [50]
Monoterpenes
Myrcene (23) C10H16 F Hydrodistillation GC-MS >10% of total volatile oil [32]
(Z)-β-Ocimene (24) C10H16 F Steam distillation GC-MS 14.0% of total volatile oil [56]
Limonene (25) C10H16 F Steam distillation GC-MS 23.6% of total volatile oil [56]
β-Phellandrene (26) C10H16 F Hydrodistillation GC-MS >9% of total volatile oil [32]
Thymol (27) C10H14O L, S Steam distillation GC-MS 18.3% of total volatile oil [57]
β-pinene (28) C10H16 F Hydrodistillation GC-MS >10% of total volatile oil [32]
Sesquiterpenes
β-elemene (29) C15H24 L Hydrodistillation GC-MS 4.53% of total volatile oil [58]
Germacrene D (30) C15H24 F, L Hydrodistillation, Steam distillation GC-MS >10% of total volatile oil [32,59]
α-Cadinol (31) C15H26O F, L Hydrodistillation GC-MS 2.2% of total detected area in GC-MS [59]
γ-Cadinene (32) C15H24 L, S Steam distillation GC-MS 13.3% of total volatile oil [57]
Bicyclogermacrene (33) C15H24 L Hydrodistillation GC-MS 2.15% of total volatile oil [58]
Guaiol (34) C15H26O F Steam distillation GC-MS >10% of total volatile oil [32]
α-humulene (35) C15H24 F, L, S MAE(n-hexane) GC-MS 10.4% of total volatile oil [33]
(E)-Caryophyllene (36) C15H24 F, AP Hydrodistillation, Steam distillation GC-MS >20% of total volatile oil [32,59]
Caryophyllene oxide (37) C15H24O F, L Steam distillation GC-MS >20% of total volatile oil [32]
Diterpene
(E)-Phytol (38) C20H40O F, L Hydrodistillation GC-MS 2.2% of total detected area in GC-MS [59]
Triterpene
α-Amyrin (39) C30H50O WP Light petrol, 90% EtOH Crystallization, St: mp, [α]D, IR [60]
β-Amyrin (40) C30H50O WP Light petrol, 90% EtOH Crystallization, St: mp, [α]D, IR [60]
3-Acetylaleuritolic acid (41) C32H50O4 AP EtOAc et. NMR, MS 23.7 mg out of 1 kg plants [34]
Lupeol (42) C30H50O AP n-Hexane ex. GC-MS Detected in moderate amount [9]
3-O-acetyl lupeol (43) C32H52O2 AP n-Hexane ex. GC-MS Detected in moderate amount [9]
Phenolic acid
Vanillic acid (44) C8H8O4 AP EtOAc ex. Recrystallization, NMR, MS 3.8 mg out of 1 kg plants [34]
Caffeic acid (45) C9H8O4 R 80% EtOH, sonication HPLC-DAD-ESI-MS From in vitro seedlings [35]
Ferulic acid (46) C10H10O4 AP MeOH ex. Recrystallization, NMR, MS 5.1 mg out of 1 kg plants [34]
Isoferulic acid (47) C10H10O4 AP MeOH ex. Recrystallization, NMR, MS 12.0 mg out of 1 kg plants [34]
3-O-caffeoylquinic acid (48) C16H18O9 R 80% EtOH, sonication HPLC-DAD-ESI-MS From in vitro seedlings [35]
5-O-caffeoylquinic acid (49) C16H18O9 R 80% EtOH, sonication HPLC-DAD-ESI-MS From in vitro seedlings [35]
3,4-di-O-caffeoylquinic acid (50)
3,5-di-O-caffeoylquinic acid (51) C25H24O12 R 80% EtOH, sonication HPLC-DAD-ESI-MS From in vitro seedlings [35]
4,5-di-O-caffeoylquinic acid (52) C25H24O12 R 80% EtOH, sonication HPLC-DAD-ESI-MS From in vitro seedlings [35]
Caffeoylmalic acid (53) C13H12O8 AP 80% EtOH, sonication HPLC-DAD-ESI-MS From in vitro seedlings [35]
Feruloylmalic acid (54) C14H14O8 AP 80% EtOH, sonication HPLC-DAD-ESI-MS From in vitro seedlings [49]
Petasiphenol (55) C18H16O7 R 80% EtOH, sonication HPLC-DAD-ESI-MS From in vitro seedlings [35]
Rosmarinic acid (56) C18H16O8 R 80% EtOH ex., sonication HPLC-ESI-MS, NMR From in vitro seedlings [49]
Flavonoid
Miquelianin (57) C21H18O13 L 80% EtOH ex., sonication HPLC-DAD-ESI-MS Peak was observed in UV chromatogram [35,61]
Rutin (58) C27H30O16 L 80% EtOH ex., sonication HPLC-DAD-ESI-MS Peak was observed in UV chromatogram [35,61]
Scopoletin (59) C10H8O4 AP MeOH ex. Recrystallization, mp, NMR 4.0 mg out of 1 kg plants [34]
Steroid
Stigmasterol (60) C29H48O AP n-Hexane ex. Recrystallization, mp 68.9 mg out of 1 kg plants [34]
Stigmasteryl-3-O-β-d-glucopyranoside (61) C35H58O6 AP CHCl3 ex. Recrystallization, mp 15.4 mg out of 1 kg plants [34]
β-sitosterol (62) C29H50O WP Light petrol, 90% EtOH St: mp, IR, co-TLC, NMR [60]
β-sitostenone (63) C29H48O AP EtOAc ex. NMR, MS 4 mg out of 1 kg plants [34]
Others
1-pentadecene (64 C15H30 F, L Hydrodistillation GC-MS 3.4% of total volatile oil [32]
[59]
(Z)-3-pentadecene (65) C16H32 WP Hydrodistillation GC-MS 4.5% of total volatile oil [62]
(E)-2-hexenol (66 C6H12O WP Hydrodistillation GC-MS 11.0% of total volatile oil [62]
(Z)-9-hexadecen-1-ol (67 C16H32O AP n-Hexane ex., soxhlet GC-MS 80.4% of relative abundance [9]
2-tridecanone (68) C13H26O WP Hydrodistillation GC-MS 13.1% of total volatile oil [62]
(7Z,9E)-2-oxoundeca-7,9-dien-1-yl senecioate, Acmellonate (69) C16H24O3 F, L Hydrodistillation GC-MS 4.7% of total detected area in GC-MS [59]
Palmitic acid (C16:0) (70) C16H32O2 AP 95% EtOH ex., maceration GC 25.8% of fixed oil, raw material from Thailand [54]
Oleic acid (C18:1 n-9) (71) C18H34O2 AP 95% EtOH ex., maceration GC 8.7% of fixed oil, raw material from Thailand [54]
Linoleic acid (C18:2 n-6) (72) C18H32O2 AP 95% EtOH ex., maceration GC 56.4% of fixed oil, raw material from Thailand [54]
WP: Whole plant; AP: Aerial part; F: Flower; L: Leave; S: Stem.
Table 4. Summary of the information on preparation of N-alkylamides from A. oleracea.
Table 4. Summary of the information on preparation of N-alkylamides from A. oleracea.
No. Part (origin) Solvent Extraction Analysis Contents Remarks Ref.
1 AP, R (in vitro seedling) 80% EtOH (1:20, w:v, 60 °C) Sonication HPLC-DAD-MS Absolute amount of 6 and total NAAs (mg/g DE)
- AP: 2.20, 2,77
- R: 0.22, 0.49
- Samples were obtained from in vitro seedlings
- Samples were prepared after defatting by Hx
[49]
2 F, L, S MeOH (1:10, w:v, 100 °C) ASE HPLC-HRMS, NMR Amount of 6 (mg/g DW) and amphiphilics (% DW)
- F: 16.50, 7.69
- L: 0.34, 8.42
- S: 0.24, 3.09
- Comparison of 6 and amphiphilic compounds in different parts of A. oleracea [45]
F, L, S CO2 (1:100, w:v, 323 K, 25 MPa)-CO2 with hydroethanolic enhancer SFE-ESE GC-FID Yield of 6 (%, DB)
- F: 65.4
- L: 19.7
- S: 47.3
- Development of optimized process for selective isolation of 6 [44]
3 F, L (Brazil) EtOH (1:5, w:v, RT) Maceration HPLC-ESI-MS/MS Order of relative abundance (%)
-F: 6 (89.2), 17 (7.9), 3, 9, 16
-L: 14 (38.0), 11 (15.8), 22 (15.5), 17 (12.7), 6* (7.6), 15 (3.8), 16 (3.2), 18, 20
- Identification and comparison of major NAAs between ethanolic extraction of flower and leave [46]
4 AP w/ F (Italy) n-Hexane (1:10, w:v, 40 °C) Sonication HPLC-MS, NMR Proportion of contents in HE (%)
- total NAAs (50.9), 6 (42.67), 17 (6.10), 3 (0.89), 9 (0.43), 16 (0.43)
[33]
5 AP w/ F (Italy) MeOH (1:10, w:v, RT) Soxhlet HPLC-DAD-IT-MS Absolute amount (g/100 g DB)
- 6 (1.9), 1 (<0.1), 3 (<0.1), 9 (<0.1), 17 (<0.1), 18 (<0.1)
- Optimization of extraction solvent and method for 6
- Contents comparison of 6 and major NAAs in different conditions
- Concentration of 6 and NAAs (Hx ex. > MeOH ex.)
- Extraction yield and absolute amount (Hx ex. < MeOH ex.)
[42]
6 AP w/ F (Italy) H2O MAE, HD GC-FID Absolute amount of 6 in EO (g/100 g)
- MAE: 13.31
- HD: 2.24
- Development of method maximizing the content of 6 in EO [33]
F (Brazil) 95% EtOH (1:4) Maceration HPLC-ESI-MS Absolute amount of 6 in ex. (mg/g)
- crude ex: 28.33
- activated charcoal treated ex: 117.96
- Increased the content of 6 and removed pigments by treatment of activated charcoal [32]
7 Whole plant 65% EtOH (1:10, w:v) - HPLC-ESI- MS Proportion among the total amount of NAA (%)
- 6 (88.8), 17 (9.0)
- Extract (A. Vogel Spilanthes) was purchased from Biohorma (Belgium)
- Permeability for 6 in the 65% ethanolic extract is two times lower compared to 10 and 30% PG based extracts in transmucosal behavior
[40]
8 AP Propane/H2O - UHPLC-DAD-ESI-MS/MS - 6, 17 were the most stable NAA
- Photostability of NAA in various solutions: MeOH>EtOH>saline>H2O
- extract was obtained from GATTEFOSSÉ (France)
- Evaluation of photostability of NAAs in various solutions
[47]
F: Flower; L: Leave; AP: Aerial part; R: Root; NAAs: N-alkylamides; DB: Dry biomass; DE: Dry extract; MAE: Microwave-assisted extraction; Hx: n-hexane extract; EO: Essential oil; HD: Hydrodistillaion; DW: Dry weight; RT: Room temperature; ASE: Accelerated solvent extractor; SFE-ESE: Supercritical fluid extraction coupled with enhanced solvent extraction.

4.2. Terpenoids

Terpenoids, the largest and most structurally diverse group of plant secondary compounds, is biosynthetically constituted by assembly of 5-carbon isoprene units (C5H8) and further categorized as several subgroups such as monoterpene, sesquiterpene, diterpene, triterpene according to the number of attached isoprene units [66,67]. Apart from the representative compound, spilanthol, most phytochemical studies on A. oleracea have focused on the monoterpenes and sesquiterpenes that constitute its essential oil. Essential oil of A. oleracea is recently attracting attention due to its various biological activity, especially insecticidal activity. Many researchers have reported the results of quantitative and qualitative analysis of components of essential oil in different parts of the plant and by different extraction methods. Most of analyses on essential oil and chemical identification were performed by comparison with analytical standards, mass spectrum overlapping or retention index calculation and comparison with those in well-established libraries such as ADAMS, FFNSC3, NIST17 by means of GC-MS [32,33,51]. Monoterpenes and sesquiterpenes are two major components in the essential oil of A. oleracea constituting around 90% with minor hydrocarbon and fatty alcohol. In accordance with commonly observed patterns, monoterpenes are more abundant that sesquiterpenes [7,33,68]. However, the monoterpene is majorly composed of monoterpene hydrocarbon rather than oxygenated monoterpene which is opposite to general cases [69]. Many studies reported major compounds in the essential oil of A. oleracea.
Among these, Baruah and Leclercq investigated chemical composition of essential oil of flower head of A. oleracea in India by steam distillation and reported limonene (23.6%), (Z)-β-ocimene (14.0%) and myrcene (9.5%) for monoterpene, β-caryophyllene (20.9%) and germacrene D (10.8%) for sesquiterpene as major constituents out of 30 detected compounds [56]. In other study utilizing same extraction method for leave and stem of A. oleracea in Brazil, thymol (18.3%) and γ-cadinene (13.3%) along with β-caryophyllene (30.2%) were reported as major constituents [57]. In separate studies utilizing hydrodistillation method, pinene (17.3%) and caryophyllene oxide (10.0%) as additional major compounds extracted by hydrodistillation from Flower of A. oleracea harvested in Italy and β-elemene and bicyclogermacrene were also identified with isolatable amount from leaves of A. oleracea [7,58]. Interestingly, Jerônimo et al reported qualitative and quantitative analysis of components in the essential oil of A. oleracea in comparison of two conventional extraction method (hydrodistillation versus steam distillation) and two different parts (flower versus leave). Total yield of essential oil from flower by hydrodistillation (0.68%) was superior to that by steam distillation (0.5%). Moreover, for most of major constituents, yield by hydrodistillation was much higher than that of steam distillation. However, 38 out of 62 were detected while 49 were detected by steam distillation. In many other plants, total yield of essential oil is higher when it is extracted by hydrodistillation and the number of identified compounds by steam distillation is more though there are some plants which showed much higher total yield by steam distillation and some compounds that could be extracted solely by the method [70,71]. β-pinene, myrcene, β-phelandrene, guaiol solely found in flower part. Including minor compounds, most of compounds were found either in both flower and leaf or only in flower part. In addition to the two conventional methods, microwave assisted extraction method is becoming popular due to its effectiveness in time and yield. Spinozzi reported higher total yield of essential oil by microwave assisted extraction as 0.47% along with maximized spilanthol content (13.31%) when compared to that by hydrodistillation (0.22% for essential oil and 2.24% for spilanthol).
As seen in the previous reports, there are various factors affecting the yield and chemical composition of essential oil such as part of plant extracted, method of extraction, cultivation environment [7,72,73]. Regardless of all these influential factors, certain terpenes, specifically, E-caryophyllene, germacrene D for aerial part including flower and myrcene and β-pinene majorly in flower consistently serve as distinctive chemical markers for A. oleracea oils, as evidenced by both existing literatures. In addition to these constituents comprising essential oil, (E)-phytol, a diterpene, was identified as isolatable amounts through GC-MS and some triterpenes such as α-amyrin, β-amyrin, lupeol, 3-acetyllupeol and 3-acetylaleuritolic acid were isolated [9,34,59,60].
Figure 4. Structures of terpenoids in A. oleracea.
Figure 4. Structures of terpenoids in A. oleracea.
Preprints 194608 g004

4.3. Phenolic Compounds

Phenolic compounds are defined by the presence of one or more hydroxyl groups directly attached to an aromatic ring, with the entire classification centered around the structure of phenol [74]. Thus, the term 'phenolics' encompasses a broad spectrum of chemical substances such as cinnamic acid derivatives, flavonoids, coumarins and lignans, which were categorized based on the number of carbons by Harborne and Simmonds [75]. Phenolic compounds have long been recognized as vital therapeutic agents for non-communicable diseases and lifestyle disorders, including cardiovascular diseases, various cancers, and age-related pathologies due to their potent antioxidant capacity to stabilize free radicals through hydrogen and electron donation [76]. Consequently, numerous studies have been reported to quantify the phenolic content and evaluate the antioxidant potential of A. oleracea. Perhaps because they have been overshadowed by alkylamides, there are surprisingly few reports on the actual isolation of individual phenolic compounds from A. oleracea. Instead, the literature has predominantly focused on the determination of total phenolic and flavonoid contents, as well as the preliminary identification of phenolic constituents. Based on the evidence from actual isolation and data confirming quantitative correlations during characterization, the structures of the identified phenolic compounds are illustrated in Figure 5. The reported compounds include vanillic acid (44), a simple phenolic acid (C6-C1); cinnamic acid derivatives (4556) (C6-C3); flavonoid glycosides (57 and 58) (C6-C3-C6) and coumarin (59).
The extraction efficiency of total phenolic contents (TPC) from A. oleracea is influenced by various physicochemical factors. Satao et al. conducted a comprehensive kinetic study focusing on solvent type, solid-to-solvent ratio, temperature, agitation speed, and pH. Regarding solvent selection, although methanol provided the highest yield (20.20 mg GAE/g DM), water was identified as the optimal solvent (17.98 mg GAE/g DM) [77]. This choice was justified by water's safety for food and pharmaceutical applications, its economic viability, and its low vapor pressure, which facilitates the maintenance of a stable solid-to-solvent ratio by minimizing evaporation.
Optimization of other parameters revealed that a 1:30 solid-to-solvent ratio was ideal, as yields plateaued beyond this point (18.52 to 18.60 mg GAE/g DM). Temperature studies showed a sharp increase in TPC up to 50°C (18.21 mg GAE/g DM), followed by a decline at 60°C, likely due to the thermal degradation of sensitive polyphenols. Furthermore, extraction was most effective at pH 5.0, with yields decreasing significantly as conditions became alkaline (pH 6–8). This aligns with the findings of Tsao, who noted that acidic conditions maintain polyphenols in a neutral state, thereby enhancing their solubility [78]. While Satao et al. recommended an agitation speed of 400 rpm, the data suggests that a plateau was not definitively reached, and higher speeds, such as 500 or 600 rpm, might yield even more favorable results.
From a biological perspective, Nascimento et al. investigated the distribution of phenolics and flavonoids across different plant parts and cultivation systems [61]. Regardless of whether the plants were field-grown (FG) or hydroponically grown (HG), leaves exhibited the highest phenolic content, followed by flowers and stems—a trend consistent with reports by Abeysiri [8]. In terms of growth systems, FG plants generally outperformed HG plants in TPC. This contrasts with studies by Abeysinghe, where HG plants and callus cultures (CC) showed higher yields. Such discrepancies may stem from variations in analytical methodologies, hydroponic techniques, or geographic cultivation regions.
Further characterization by Ferrara compared the aerial parts (AP) and roots (R) [49]. While AP extracts were rich in both phenols and alkylamides (including spilanthol), R extracts contained significantly higher phenolic levels (14.15 mg/g DE) despite much lower alkylamide content. Notably, the neuroprotective effect of the root extract was comparable to that of the aerial parts, suggesting that phenolic compounds play a crucial role in this bioactivity. The root profile was dominated by 3,5-di-O-caffeoylquinic acid (51), accounting for over 50% of its TPC, whereas the aerial parts contained a more diverse but lower-concentration mixture of phenolics, including caffeoylmalic acid (53) and feruloylmalic acid (54). Detailed data on these phenolic constituents and the factors influencing their extraction are summarized in Table 5.
In addition to the widely studied alkylamides, monoterpenes and sesquiterpenes in essential oils, and phenolic compounds investigated for their antioxidant properties, several other lipophilic compounds have been identified in A. oleracea. These primarily include substances with a steroid backbone (6063) and various hydrocarbons along with their oxidized derivatives (6472). Notably, stigmasterol (60), stigmasteryl-3-O-β-d-glucopyranoside (61), and β-sitostenone (63) were isolated through antioxidant and antimicrobial activity-guided fractionation [34]. Furthermore, numerous hydrocarbons and their derivatives are frequently identified in essential oils via GC-MS analysis [9,32,59,62]. Among these, (Z)-9-hexadecen-1-ol (67) exhibited a high relative abundance of 80.4% in the total ion chromatogram (TIC) [9].
Finally, Phrutivorapongkul et al. reported on the composition of fixed oils in A. oleracea. In the field of food and nutrition, it is well-established that the degree of unsaturation and the specific types of fatty acids within vegetable oils play a crucial role in determining their food industrial applications and ethno-pharmacological benefits [79,80]. According to the report, the fixed oil fraction of A. oleracea is predominantly composed of alpha-linolenic acid (72) (56.37%), an essential omega-3 (ω-3) fatty acid. This was followed by palmitic acid (70) (25.85%), a saturated fatty acid, and oleic acid (71) (8.72%), a monounsaturated fatty acid. These findings suggest that A. oleracea possesses superior nutritional value due to its high content of unsaturated fatty acids, particularly polyunsaturated fatty acids (PUFAs) like alpha-linolenic acid.
Figure 6. Structures of miscellaneous lipophilic compounds in A. oleracea.
Figure 6. Structures of miscellaneous lipophilic compounds in A. oleracea.
Preprints 194608 g006

5. Biological Activities

A. oleracea, which is utilized globally both as a botanical and in various nutraceutical forms, has been the subject of extensive modern pharmacological investigations that align with its diverse traditional applications. Extensive research has identified a broad spectrum of pharmacological activities for A. oleracea, including anti-inflammatory, antioxidant, analgesic, and antimicrobial effects, as well as vasorelaxant, antiarrhythmic, and wound-healing properties. These findings strongly validate the plant's traditional applications, which have guided modern scientific inquiry into its multifaceted therapeutic value. A comprehensive summary of these activities is provided in Table X.

5.1. Anti-Inflammatory Activities

Unresolved inflammation acts as a primary catalyst for various pathologies. The chronicity of the inflammatory process poses a fundamental danger, as it triggers a self-perpetuating cycle where inflammatory tissue damage leads to necrosis, which in turn further exacerbates the inflammatory response [81]. Traditionally, A. oleracea has been utilized to treat respiratory conditions such as throat complaints and tuberculosis [31]. In a study by Kim et al., the protective effects and underlying mechanisms of a methanol extract from the whole S. acmella plant were evaluated using an LPS-induced lung injury mouse model. Administration of the extract at doses of 1 and 10 mg/kg resulted in a dose-dependent inhibition of inflammation, as confirmed by histological analysis. Furthermore, the extract suppressed neutrophilic lung inflammation by reducing the mRNA expression of proinflammatory cytokines (IL-1β, IL-6, and TNF-α) and lowering the activity of myeloperoxidase (MPO), a key inflammatory marker in neutrophils. To further elucidate the molecular mechanisms, in vitro assays using RAW 264.7 cells demonstrated that the extract dose-dependently inhibited the nuclear localization of NF-κB and decreased the expression of NF-κB-dependent cytokine genes (IL-6 and IL-1β). Simultaneously, it enhanced the antioxidant defense by inhibiting the ubiquitination of Nrf2, thereby increasing nuclear Nrf2 levels and the expression of Nrf2-dependent genes such as NQO1. These findings collectively suggest that A. oleracea mitigates lung inflammation through the dual regulation of NF-κB inhibition and Nrf2 activation [82].
Another study reported the anti-inflammatory activity of an aqueous extract from the aerial parts using a carrageenan-induced rat paw edema model. While the positive control, aspirin (100 mg/kg), showed an inhibition rate of 63.1%, the extract demonstrated paw edema inhibition of 52.6%, 54.4%, and 56.1% at doses of 100, 200, and 400 mg/kg, respectively. These results suggest that hydrophilic compounds, such as polysaccharides and phenolic substances, may have significant anti-inflammatory potential [23]. In a study comparing the anti-inflammatory activities of different fractions, an 85% EtOH extract from A. oleracea flowers was subjected to sequential partitioning to obtain n-hexane, CHCl3, ethyl acetate, and n-butanol fractions. Their ability to inhibit LPS-induced NO production in RAW 264.7 cells was evaluated. The results indicated that at a concentration of 80 ug/mL, the CHCl3 fraction exhibited the highest potency with 85% inhibition of NO production, followed by the n-hexane fraction (72%), ethyl acetate fraction, and n-butanol fraction in descending order. Regarding spilanthol (6) (45, 90, and 180 uM), the most widely recognized active compound, it dose-dependently inhibited the mRNA expression and protein production of LPS-induced iNOS (inducible nitric oxide synthase) and COX-2 (cyclooxygenase-2) in RAW 264.7 cells. Furthermore, it significantly suppressed the secretion of proinflammatory cytokines, such as IL-1β and IL-6. Mechanistically, spilanthol (6) was found to inhibit the LPS-induced phosphorylation of cytoplasmic IκB and the DNA binding activity of NF-κB in a dose-dependent manner. These findings indicate that, consistent with the previously reported results about inflammatory activity at extract or fraction level, the anti-inflammatory efficacy of spilanthol is mediated through the inactivation of the NF-κB signaling pathway [83].
Huang et al. reported the inhibitory effects of spilanthol (6) on allergic inflammation using a DNCB-induced atopic dermatitis mouse model. Treatment with spilanthol (6) at doses of 5 and 10 mg/kg significantly suppressed the elevation of IgE and IgG2a, which are key markers of allergic reactions. Furthermore, it was found to modulate the Th1/Th2 imbalance by increasing IgG1 levels. These therapeutic effects were attributed to the inhibition of the MAPK signaling pathway, specifically by suppressing the activation of ERK, JNK, and p38 proteins. Additionally, spilanthol (6) administration reduced epidermal thickness, collagen accumulation, and the infiltration of mast cells and eosinophils. Collectively, the study demonstrated that spilanthol (6) ameliorates allergic inflammation in DNCB-induced atopic lesions by improving mast cell infiltration, modulating Th1/Th2 cytokine levels, and inhibiting MAPK signaling. Additionally, spilanthol (6) administration reduced epidermal thickness, collagen accumulation, and the infiltration of mast cells and eosinophils. Collectively, the study demonstrated that spilanthol (6) ameliorates allergic inflammation in DNCB-induced atopic lesions by improving mast cell infiltration, modulating Th1/Th2 cytokine levels, and inhibiting MAPK signaling [84].

5.2. Antioxidant Activities

Due to its rich content of phenolic compounds, numerous studies have reported the antioxidant potential of A. oleracea. Wangsawatkul et al. evaluated the antioxidant capacities of the aerial parts extracted with various solvents (hexane, CHCl3, ethyl acetate, and MeOH) using DPPH radical scavenging and SOD (superoxide dismutase) activity assays. At a concentration of 200ug/mL, the ethyl acetate (EA) and methanol (MeOH) extracts exhibited similarly potent DPPH radical scavenging activities at 47.90% and 47.76%, respectively, followed by the CHCl3 and hexane extracts.In contrast, when SOD activity was assessed via NBT (nitroblue tetrazolium) inhibition, the CHCl3 extract demonstrated the highest activity (57.92%). This was followed by the MeOH (47.02%) and EA (33.05%) extracts, while the hexane extract showed negligible activity (0.41%) [85]. Prachayasittikul et al. conducted experiments under nearly identical conditions and reported a consistent order of efficacy among the extracts. Notably, they reported the isolation and identification of four phenolic compounds (44, 46, 47, 59), one terpenoid (41), and three steroids (60, 61, 63) from the active fractions. However, the biological activities of these individual isolated compounds were not further evaluated [34].
In a study investigating the activity of different plant parts and solvent extracts, the DPPH radical scavenging activity was found to be highest in the flowers, followed by the stems and leaves. Regarding the solvents used, the methanol extract exhibited the greatest potency, followed by the acetone and water extracts, respectively [86]. Meanwhile, Fajardo et al. comprehensively evaluated the efficacy of the methanol extract from A. oleracea leaves. At a concentration of 300 ug/mL, the extract reduced IFN-γ and LPS-induced ROS production in macrophages by approximately 69.03%. In the NO scavenging assay, it exhibited an IC50 value of 127.6 ug/mL for the inhibition of NO production. Furthermore, the extract showed a 63.69% inhibition rate regarding the production of MDA, a byproduct of lipid peroxidation. In addition to these findings, the study provided insights into the correlation between potent antioxidant capacity and phenolic content through total phenolic content (TPC) determination and compositional analysis [87].
At the single-compound level, the efficacy of known active substances, vanillic acid (44) and trans-ferulic acid (46), has been reported in SH-SY5Y neuronal cell model where neurotoxicity was induced by H2O2. Both 44 and 46 were found to inhibit apoptosis and reduce ROS levels. Furthermore, pretreatment with these phenolic compounds effectively counteracted the H2O2-driven decline of SIRT1 and FoxO3a expressions in SH-SY5Y cells. This molecular upregulation was accompanied by an increase in key antioxidant enzymes, such as SOD2 and catalase, as well as the anti-apoptotic protein Bcl-2, thereby reinforcing the cellular defense against oxidative damage [88].

5.3. Analgesic Activity

A study investigating the analgesic properties of the aqueous extract of A. oleracea reported significant results in multiple pain models. In acetic acid-induced writhing tests using albino mice, administration of the extract at doses of 100, 200, and 400 mg/kg resulted in protection rates of 46.9%, 51.0%, and 65.6%, respectively. Although these values were slightly lower than the 79.7% protection rate of the positive control, aspirin (100 mg/kg), they nonetheless demonstrate substantial analgesic efficacy. Furthermore, in the tail flick test, the extract was found to significantly increase the pain threshold throughout the entire observation period (30 min, 1, 2, and 4 h post-administration) [23]. Dallazen et al. provided critical insights into the mechanistic aspects of the antinociceptive properties of A. oleracea. The researchers evaluated the effects of an alkylamide-rich hexane fraction from the flower ethanol extract using the formalin test at two distinct concentrations: an antinociceptive dose (5 ug/mL) and a pronociceptive dose (1.5 mg/mL). At the low dose, the extract significantly inhibited glutamate-induced pain in both the neurogenic and inflammatory phases. This effect was independent of the endogenous opioidergic system but was closely associated with TRPV1 modulation. Conversely, the pain-inducing behavior observed at the high dose was attenuated by the activation of the opioidergic system, treatment with TRPA1 antagonists, and the desensitization of TRP nociceptive fibers. Collectively, these findings demonstrate that alkylamides can exert contrasting biphasic effects depending on the dosage and provide specific information regarding the receptors involved [89].
A study reporting the antinociceptive activity of MeOH extracts (100 mg/kg) from different plant parts found that in the neurogenic phase of the formalin test, the aerial part extract exhibited stronger activity than the flower extract. Conversely, in the inflammatory phase, the flower extract showed greater potency than the aerial part extract. Both extracts demonstrated efficacy comparable to that of indomethacin. Furthermore, results from the open field and catalepsy tests showed no significant differences compared to the control group. This indicates that the extracts did not induce hypolocomotion or catalepsy, which are potential side effects typically associated with cannabinoid receptor agonists [90].

5.4. Anesthetic Activity

Chakraborty et al. validated the anesthetic efficacy of the aqueous extract of A. oleracea through in vivo testing. An intracutaneous wheal test conducted in guinea pigs at two concentrations, 10% and 20%, demonstrated dose-dependent anesthetic effects of 70.36% and 87.02%, respectively, compared to only 4.16% in the negative control group. Furthermore, in a plexus anesthesia test using frogs, the 20% concentration showed a mean anesthetic onset time of 5.33 minutes. Considering the negative control's onset time of 24.15 minutes, these results indicate substantial anesthetic potency [91]. Next, the potential of A. oleracea as a fish anesthetic was demonstrated in a study where a spilanthol-rich fraction, obtained via supercritical fluid extraction (SFE), was administered to juvenile tambaqui (Colossoma macropomum). The results showed that deep anesthesia was effectively achieved at all tested levels, with 20 mg/L yielding the most efficient induction (< 3 min) and recovery (< 5 min) times. While a minimal dose of 2 mg/L provided effective sedation, the overall stress response remained minimal; all physiological indicators fully recovered within 48 hours, highlighting the potential of jambu extract as a safe and potent anesthetic agent [92].

5.5. Antimicrobial Activity

Mbeunkui et al. reported the antiplasmodial activity of A. oleracea and the potential synergistic effects among its constituents. An alkylamide-rich fraction, derived from the methanol extract of the flowers, was tested against the chloroquine-sensitive (D10) strain of Plasmodium falciparum, followed by bioactivity-guided fractionation and isolation.The IC50 values for the active fractions 2 to 5 were 14.91, 22.04, 26.17, and 12.21 ug/mL, respectively. Subsequently, the major compounds (1, 6, 9, and 17) were isolated from these four fractions, yielding IC50 values of 54.03, 26.43, 29.34, and 33.73 ug/mL, respectively. A comparison between the fractions and their respective major compounds suggests a potential synergistic effect. Specifically, fraction 2, which contains 1 as its primary constituent alongside a balanced proportion of other alkylamides, including spilanthol (6) demonstrated significantly higher activity than fraction 3, which consists of over 95% spilanthol (6). Notably, although 1 itself was approximately twofold less active than 6, its corresponding fraction (fraction 2) outperformed fraction 3, reinforcing the hypothesis that the coexistence of multiple alkylamides enhances the overall antiplasmodial efficacy [48].
On the other hand, several studies have reported the antimicrobial activity of A. oleracea against a diverse range of microbial strains. Specifically, the methanol extract from the leaves exhibited antibacterial activity against E. coli, S. epidermidis, MRSA, and P. aeruginosa, as well as antifungal activity against C. albicans, with MIC (Minimum Inhibitory Concentration) values ranging from 125 to 1000 ug/mL. Notably, when assessing adhesion inhibition against S. aureus, P. aeruginosa, and their mixed biofilms, the extract showed inhibition rates of 44.71%, 95.5%, and 51.83%, respectively. Furthermore, it demonstrated significant growth inhibition of 77.17% for S. aureus and 62.36% for P. aeruginosa [87].
Prachayasittikul et al. evaluated the antimicrobial activities of various solvent extracts (n-hexane, CHCl3, ethyl acetate, and methanol) from aerial part of A. oleracea against an extensive range of microbial strains, including C. diphtheriae, S. cerevisiae, S. pyogenes, B. subtilis, M. luteus, S. epidermidis, and P. shigelloides. Overall, fractions derived from the CHCl3 and methanol extracts exhibited potent growth inhibition against most of the tested strains. For instance, these fractions yielded MIC values ranging from 64 to 256 ug/mL against C. diphtheriae and 128 to 256 ug/mL against B. subtilis [34].

5.6. Vasorelaxant Activity

Wongsawatkul et al. reported the vasorelaxant effects of various solvent extracts (hexane, CHCl3, ethyl acetate, and methanol) from A. oleracea using an in vivo model. After inducing contraction in the rat thoracic aorta with phenylephrine, the efficacy and underlying mechanisms of the extracts were evaluated through solo administration or co-treatment with a NOS (nitric oxide synthase) inhibitor or a COX (cyclooxygenase) inhibitor. The results showed that the maximal relaxation (Rmax) for the hexane, CHCl3, ethyl acetate, and methanol extracts were 65.67%, 96.64%, 81.64%, and 65.09%, respectively. Furthermore, the ED50 values were recorded at 0.361, 0.428, 0.076, and 0.955 ng/mL, respectively. These findings indicate that the ethyl acetate extract induced the most rapid vasorelaxation, while the CHCl3 extract exhibited the highest overall vasorelaxant potency [85].
Meanwhile, a study reporting the vasorelaxant effect of spilanthol (6) and its plausible mechanisms revealed that this effect was partly dependent on the presence of the endothelium. Furthermore, the vasorelaxation was significantly inhibited in the presence of inhibitors of nitric oxide (NO), hydrogen sulfide (H2S), and carbon monoxide (CO) synthesis. These findings suggest that spilanthol-induced vasodilation is mediated by complex mechanisms involving both gasotransmitters and prostacyclin signaling pathways [93]

5.7. Others

In addition to the aforementioned activities, other pharmacological properties such as wound healing, antipyretic, antiarrhythmic, and gastroprotective effects have been reported. Regarding wound healing, a scratch wound healing assay using L929 fibroblasts demonstrated that the methanol extract from A. oleracea leaves achieved 97.86% cell migration compared to the control group. This result provides a scientific basis for its traditional use in wound recovery [87].
The antipyretic activity of the aqueous extract from the aerial parts was evaluated in a yeast-induced pyrexia rat model. At doses of 100, 200, and 400 mg/kg, the extract significantly reduced body temperature from 1 to 3 hours post-administration, performing comparably to the positive control, aspirin (300 mg/kg). However, unlike aspirin, the antipyretic effect did not persist at the 4-hour mark. The authors attributed this transient effect to phenolic compounds, such as flavonoids, present in the fractions [91].
Furthermore, the antiarrhythmic activity of a spilanthol-rich fraction obtained via supercritical fluid extraction was investigated. Its electrophysiological effects and impact on epinephrine-induced arrhythmia were evaluated. At doses of 10, 15, and 20 mg/kg, the fraction maintained sinus rhythm and preserved cardiac intervals, while significantly reducing the heart rate and R-R interval. These results were found to be comparable to those of lidocaine [94].
Lastly, the gastroprotective effect of polysaccharides derived from A. oleracea has been reported, which is a relatively unique finding regarding both the material and its efficacy. In an ethanol-induced gastric ulcer rat model, the administration of rhamnogalacturonans (polysaccharides) dose-dependently reduced gastric lesions, with an ED50 of 1.5 mg/kg. The underlying gastroprotective mechanisms are hypothesized to involve: (1) the formation of a protective physical barrier by binding to the mucosal surface; (2) the suppression of aggressive factors, specifically acid and pepsin secretions; and (3) the enhancement of mucosal defense through stimulated mucus synthesis and effective radical scavenging activity [95].
Table 6. Summary of biological activity of A. oleracea.
Table 6. Summary of biological activity of A. oleracea.
Activity Cpd, ex., fr. (part) Assay/Cell type/Model Concentration Result or mechanism Ref.
Anti-inflammatory MeOH ex. (WP) In vivo (C57BL/6 mice)- histology, RT-PCR, MPO assay 1, 10 mg/kg () Expression of IL-1
, IL-6, TNF-α
() MPO activity
() Neutrophilic lung inflammation in histology
[82]
MeOH ex. (WP) In vitro (RAW264.7 cell lines) 10, 30 and 50 ug/mL
() Nuclear localization of NF-κB
() Expression of NF-κB dependent
cytokine genes
() Ubiquitination of Nrf2
() Level of Nrf2 in the nucleus
() Expression of Nrf2-dependent genes
[82]
Water ex. (AP) In vivo (Albino Wistar rat)-paw edema test 100, 200 and 400 mg/kg
() Paw edema at three doses
(inhibition %: 52.6, 54.4, 56.1)
[23]
Hx fr., CHCl3 fr., EA fr., Bu fr. from 85%EtOH ex. (F) In vitro (RAW264.7 cell lines) 80 ug/mL CHCl3 fr. and Hx fr.
() NO production significantly
[83]
6 In vitro (RAW264.7 cell lines)-LPS induced inflammation 45, 90, 180 uM
() LPS-induced iNOS and COX-2 mRNA and protein expression
() Proinflammatory cytokines (IL-1β, IL-6, TNF-α)
() LPS-induced p-IκB, NF-κB DNA binding activity
[83]
6 In vivo (BALB/c mice)- DNCB induced AD-like skin lesions 5, 10 mg/kg
() IgE, IgG2a, COX-2, iNOS expression via blocking MAPK pathway
() Epidermal thickness, collagen accumulation, mast cell, eosinophil infiltration
[84]
Antioxidant Hx ex., CHCl3 ex., EA ex., MeOH ex. (AP) In vitro-DPPH radical scavenging assay, SOD activity assay 200 ug/mL Radical scavenging activity (%)
: 4.90, 29.82, 47.90 and 47.76
(Hx ex., CHCl3 ex., EA ex., MeOH ex.)
NBT inhibition (%)
: 0.41, 57.92, 33.05 and 47.02
(Hx ex., CHCl3 ex., EA ex., MeOH ex.)
[85]
Hx ex., CHCl3 ex., EA ex., MeOH ex. (AP) In vitro-DPPH radical scavenging assay, SOD activity assay 300 ug/mL Radical scavenging activity
: EA ex. and MeOH ex. showed the most potent activity
NBT inhibition
: CHCl3 ex. exhibited the most potent SOD activity
Activity guided isolation
: Phenolic compounds (44, 46, 47, and 59) and a terpenoid (41) and steroids (60, 61, and 63) from active fr.
[34]
Hx fr., CHCl3 fr., EA fr., Bu fr. from 85% EtOH ex. (F) In vitro-DPPH, ABTS radical scavenging assay EC50 DPPH, ABTS radical scavenging assay
: EA fr. showed strongest antioxidant activity (1.38, 3.32 umol)
[83]
Ace ex., MeOH ex., Water ex. (F, S, L) In vitro-DPPH radical scavenging assay EC50 Radical scavenging activity
: MeOH ex. showed strongest activity, followed by acetone ex. and water ex. in all parts
: ex. of F showed strongest activity, followed by ex. of S and L in MeOH ex.
[86]
MeOH ex. (L) In vitro (BALB/c peritoneal macrophages)- Evaluation of ROS level, DPPH, NO scavenging assay, MDA assay Evaluation of ROS level
: 18.75–300 ug/mL
NO scavenging assay and DPPH radical scavenging assay
: IC50
MDA assay
: 7.5–30 ug/mL
Reduction of production of ROS (%)
: 69.0 (300 ug/mL)
IC50 (ug/mL)
: 44.5 (DPPH) and 127.6 (NO)
MDA assay
: 63.69%
[87]
44 and 46 In vitro (SH-SY5Y cells)- Cell viability, Carboxy-DCFDA assay 1, 5 uM
() H2O2 induced toxicity, ROS level
() Expression of SIRT1 and FoxO 3a
() Levels of SOD2 and CAT, Bcl-2 proteins
[88]
Analgesic Water ex. (AP) In vivo (Swiss albino mice and Wistar albino rats)-Writhing test,
tail flick test
100, 200 and 400 mg/kg Protection from writhing (%)
: 46.9, 51.0 and 65.6
Tail flick test
: Increased the pain threshold significantly
[23]
Hx fr. from EtOH ex. (F) In vivo (male Swiss mice)-Chemical and sensorial test 5 ug/mL (antinociceptive)
1.5 mg/mL (pronociceptive)
: Exhibited dual effects depending on doses
: Antinociceptive effect at low dose was not inhibited by opioid blocker, but by TRPV1 modulation
: Pronociceptive effect at high dose was inhibited by opioid agonist, TRPA1 antagonist and TRP nociceptive fiber desensitization
[89]
MeOH ex. (F and AP) In vivo (both sexes Swiss mice)-Formalin test, open field test, and catalepsy test 100 mg/kg Antinociceptive activity (neurologenic phase)
: AP ex. > F ex.
Antinociceptive activity (inflammatory phase)
: F ex. > AP ex.
Open field and catalepsy test (F ex.)
: no difference compared to control
[90]
Anesthetic Water ex. (AP) In vivo (guinea pigs and frogs)-Intracutaneous wheal test and plexus anesthesia in frogs 10, 20% Anesthesia effect (%) in intracutaneous wheal method
: 70.36, 87.02 (10, 20% conc.)
Mean onset of anesthesia (min) in Plexus Anesthesia Method
-samples (20% conc.): 5.33
[91]
SFE ex. (F) In vivo (fishes)-Determination of time of anesthetic induction and recovery 5–25 mg/L Deep anesthesia at all conc.
20 mg/L is recommended for rapid induction (<3 min) and uneventful recovery (<5 min)
Most of blood parameters were returned within 48 h post-anesthesia
[92]
Antiplasmodial MeOH ex. (F) In vitro (chloroquine sensitive strain (D10) of P. falciparum) IC50
IC50 (ug/mL)
: 14.91, 22.04, 26.17 and 12.21
(active fraction 2–5)
: 54.03, 26.43, 29.34 and 33.73
(cpd 1, 6, 9, 17):
[48]
Antibacterial MeOH ex. (L) In vitro (E. coli, S. epidermis, MRSA, P. aeruginosa, C. albicans)
- MIC, MBC, MFC
- Bacterial killing assay
- Evaluation of biofilms adhesion inhibition
MIC: 1000 – 125 ug/mL
Adhesion of biofilm (%)
: 44.71, 95.5 and 51.83 (S. aureus, P. aeruginosa and mixed)
Growth inhibition (%)
77.17, 62.36 (S. aureus, P. aeruginosa)
[87]
Hx ex., CHCl3 ex., EA ex., MeOH ex. (AP) In vitro (C. diphtheriae, S. cerevisiae, S. pyogenes, B. cereus, B. subtilis, M. lutens, S. epidermis, P. shigelloides)
- MIC
Fr. from CHCl3 and MeOH ext.
() Growth of many tested organisms
(e.g. C. diphtheriae MIC of 64-256 μg/mL and B. subtilis with MIC of 128-256 μg/mL)
[34]
Vasorelaxant Hx ex., CHCl3 ex., EA ex., MeOH ex. (AP) In vivo (male Sprague-Dawley rats)
-Isometric tension measurement
ED50
Relaxation max (%)
: 65.67, 96.64, 81.64 and 65.09
(Hx ex.. CHCl3 ex., EA ex., MeOH ex.)
ED50 (ng/mL)
: 0.361, 0.428, 0.076 and 0.955
(Hx ex.. CHCl3 ex., EA ex., MeOH ex.)
[85]
6 In vivo (male Wistar rats)
-Isometric tension measurement
Vasorelaxation was partly dependent on the presence of endothelium
(↓) Vasorelaxation in the presence of inhibitors of NO, H2S, and CO synthesis
(↑) Vasodilation by mechanisms that involve gasotransmitters and prostacyclin signaling pathways
[93]
Wound healing MeOH ex. (L) In vitro (L929 fibroblast)
-Scratch wound healing assay with
18.75, 37.50 ug/mL () migration (97.86%) [87]
Antipyretic Water ex. (AP) In vivo (albino rats)-yeast-induced pyrexia model 100, 200, 400 mg/kg Antipyretic effect
(↓) temperature of pyretic rats significantly
from 1 h to 3 h
[91]
Antiarrhythmic 6 rich fr. obtained by SFE In vivo (male Wistar rats)
- Assessment of cardiac electrophysiology
- Epinephrine-induced arrhythmia
10, 15, 20 mg/kg
Maintained sinus rhythm and preserved cardiac intervals
(↓) Reduction in heart rate and R-R interval significantly
[94]
Gastroprotective Polysaccharide (L)
In vivo (female Wistar rats)
- EtOH-induced gastric ulcers model
1, 3, 10, and 30 mg/kg
ED50
(↓) EtOH-induced gastric lesion
ED50 (mg/kg)
: 1.5
[95]
WP: Whole plant; AP: Aerial part; F: Flower; L: Leave; S: Stem; Cpd: Compound; ex.: Extract; fr.: Fraction; Hx : n-hexane; EA: ethyl acetate; Bu: n-BuOH; Ace: Acetone; iNOS: inducible nitric oxide synthase; p-IκB: phosphorylated inhibitor of kappa B; NF-κB: nuclear factor kappa B; DNCB: 2,4-dinitrochlorobenzene; AD: atopic dermatitis; IL-1β: Interleukin-1β; IL-6: Interleukin-6; iNOS: inducible nitric oxide synthase; COX-2: cyclooxygenase-2; IgE: Immunoglobulin E; IgG2a: Immunoglobulin G2a; IgG1: Immunoglobulin G1; Th1: T helper 1 cell; Th2: T helper 2 cell; MAPK: Mitogen-activated protein kinase; ERK: Extracellular signal-regulated kinase; JNK: c-Jun N-terminal kinase; DE: Dry extract; DPPH: 2,2-diphenyl-1-picrylhydrazyl; SOD: superoxide dismutase; INF-γ: Interferon γ; ROS: Reactive oxygen species; NO: Nitric oxide; Carboxy-DCFDA: Carboxy-2',7'-dichlorofluorescein diacetate; conc.: Concentration; SFE: Supercritical fluid extraction; P. falciparum: Plasmodium falciparum;.

4. Conclusions

Through this review, A. oleracea has been reaffirmed as a valuable natural resource that combines rich ethnopharmacological traditions with modern scientific evidence. N-alkylamides, led by the key constituent spilanthol (6), along with phenolic compounds, possess multifaceted therapeutic potential, including anti-inflammatory, analgesic, and anesthetic effects. This potential is translating into active patent filings and commercialization in industrial sectors such as oral care products and cosmeceuticals. Unlike previous reviews that addressed the entire genus broadly, this study distinguishes itself by systematically collecting the latest research findings specific to A. oleracea and organizing compounds selected for their high quantitative reliability. Such an integrative analysis will contribute to researchers identifying existing knowledge gaps and establishing more effective extraction processes and formulation strategies.
Future research should involve clinical trials based on the various pharmacological mechanisms presented in this review, alongside more in-depth standardized marker compound management for industrial mass production and long-term toxicological assessments. It is expected that this paper will serve as a significant milestone in the development of high-value natural medicines and functional materials utilizing A. oleracea.

Author Contributions

Conceptualization, investigation, writing, B.W.L. All authors have read and agreed to the published version of the manuscript.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

No new data were created or analyzed in this study. Data sharing is not applicable to this article.

Acknowledgments

I extend my deepest gratitude to C.L. Pharm Co., Ltd. for supporting this work and Pf. Jin-Yang Kang for his invaluable support and advice.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Lim, T.K. Edible medicinal and non-medicinal plants: Flowers. In Springer; Springer Science+Business Media Dordrecht: Dordrecht, Netherland, 2014; Volume 7, pp. 163–174. [Google Scholar]
  2. Paulraj, J.; Govindarajan, R.; Palpu, P. The Genus Spilanthes Ethnopharmacology, Phytochemistry, and Pharmacological Properties: A Review. Adv. Pharmacol. Sci. 2013, 2013, 510298. [Google Scholar] [CrossRef] [PubMed]
  3. Panyadee, P.; Inta, A. Taxonomy and ethnobotany of Acmella (Asteraceae) in Thailand. Biodiversitas 2022, 23, 2177–2186. [Google Scholar] [CrossRef]
  4. Silveira, N.; Sandjo, L.P.; Bavatti, M.W. Spilanthol-containing products: A patent review (1996–2016). Trends Food Sci. Technol. 2018, 74, 107–111. [Google Scholar] [CrossRef]
  5. Jansen, R.K. The Systematics of Acmella (Asteraceae-Heliantheae). Syst. Bot. Monogr. 1985, 8, 1–115. [Google Scholar] [CrossRef]
  6. Chung, K.; Kono, Y.; Wang, C.; Peng, C. Notes on Acmella (Asteraceae: Heliantheae) in Taiwan. Bot. Stud. 2008, 49, 73–82. [Google Scholar]
  7. Benelli, G.; Pavela, R.; Drenaggi, E.; Maggi, F. Insecticidal efficacy of the essential oil of jambú (Acmella oleracea (L.) R.K. Jansen) cultivated in central Italy against filariasis mosquito vectors, houseflies and moth pests. J. Ethnopharmacol. 2019, 229, 272–279. [Google Scholar] [CrossRef]
  8. Abeysiri, G.R.P.I.; Dharmadasa, R.M.; Abeysinghe, D.C.; Samarasinghe, K. Screening of phytochemical, physico-chemical and bioactivity of different parts of Acmella oleraceae Murr. (Asteraceae), a natural remedy for toothache. Ind. Crops Prod. 2013, 50, 852–856. [Google Scholar] [CrossRef]
  9. Lalthanpuii, P.B.; Lalchhandama, K. Chemical composition and broad-spectrum anthelmintic activity of a cultivar of toothache plant, Acmella oleracea, from Mizoram, India. Pharm. Biol. 2020, 58, 393–399. [Google Scholar] [CrossRef]
  10. Sharma, U.K.; Pegu, S. Ethnobotany of religious and supernatural beliefs of the Mising tribes of Assam with special reference to the ‘Dobur Uie’. J. Ethnobiol. Ethnomed. 2011, 7, 16. [Google Scholar] [CrossRef]
  11. Hind, N.; Bigg, N. Plate 460. Acmella oleracea Compositae’. Curtis’s Bot. Mag. 2003, 20, 31–39. [Google Scholar] [CrossRef]
  12. Revathi, P.; Parimelazhagan, T. Traditional knowledge on medicinal plants used by the Irula tribe of Hasanur hills, Erode district, Tamil Nadu, India. Ethnobotanical Leaflets 2010, 14, 136–160. [Google Scholar]
  13. Álvarez-Vásquez, J.L.; Parra-Solano, N.F.; Saavedra-Cornejo, G.E.; Espinosa-Vásquez, X.E. Global use of Ethnomedicinal Plants to Treat Toothache. Biomed. Pharmacol. J. 2022, 15, 847–881. [Google Scholar] [CrossRef]
  14. Rahim, R.A.; Jayusman, P.A.; Muhammad, N.; Mohamed, N.; Lim, V.; Ahmad, N.H.; Mohamad, S.; Hamid, Z.A.A.; Ahmad, F.; Mokhtar, N.; Shuid, A.N.; Mohamed, N. Potential Antioxidant and Anti-Inflammatory Effects of Spilanthes acmella and Its Health Beneficial Effects: A Review. Int. J. Environ. Res. Public Health 2021, 18, 3532. [Google Scholar] [CrossRef] [PubMed]
  15. Vijendra, N.; Kumar, K.P. Traditional knowledge on ethno-medicinal uses prevailing in tribal pockets of Chhindwara and Betul Districts, Madhya Pradesh, India. Afr. J. Trop. Agric. 2017, 5, 1–9. [Google Scholar]
  16. Joseph, B.; George, J.; Jeevitha, M.V. THE ROLE OF ACEMELLA OLERACEA IN MEDICINE- A REVIEW. WJPR 2013, 2, 2781–2792. [Google Scholar]
  17. Dubey, S.; Maity, S.; Singh, M.; Saraf, S.A.; Saha, S. Phytochemistry, Pharmacology and Toxicology of Spilanthes acmella: A Review. Adv. Pharmacol. Sci. 2013, 2013, 423750. [Google Scholar] [CrossRef]
  18. Hossan, M.S.; Hanif, A.; Agarwala, B.; Sarwar, M.S.; Karim, M.; Taufiq-Ur-Rahman, M.; Jahan, R.; Rahmatullah, M. Traditional Use of Medicinal Plants in Bangladesh to Treat Urinary Tract Infections and Sexually Transmitted Diseases. Ethnobot. Res. Appl. 2010, 8, 61–74. [Google Scholar] [CrossRef]
  19. Biswas, A.; Bari, M.A.; Roy, M.; Bhadra, S.K. Inherited folk pharmaceutical knowledge of tribal people in the Chittagong Hill tracts, Bangladesh. Indian J. Tradit. Knowl. 2010, 9, 77–89. [Google Scholar]
  20. Santesson, C.G. Several drugs of the Cameroon District and their native uses. Archiv Fur die Botanik 1926, 20, 1–34. [Google Scholar]
  21. Burkill, I.H. A dictionary of the economic products of the malay peninsula. Second edition; Burkill, H.M., Ed.; Ministry of Agriculture and Co-operatives: Kuala Lumpur, Malaysia, 1966. [Google Scholar]
  22. Bailey, L.H. Manual of cultivated plants most commonly grown in the continental United States and Canada. In The Macmillan Co., revised edn; New York, U.S, 1949; p. 1116. [Google Scholar]
  23. Chakraborty, A.; Devi, R.K.B.; Rita, S.; Sharatchandra, K.; Singh, T.I. Preliminary studies on antiinflammatory and analgesic activities of Spilanthes acmella in experimental animal models. Indian J. Pharmacol. 2004, 36, 148–150. [Google Scholar]
  24. Benwick, B.S. Like a taste that tingles? Then this bud is for you. Washington Post. 2007. Available online: http://www.washingtonpost.com/wp-dyn/content/article/2007/10/02/AR2007100200464.html.
  25. Ochse, J.J.; Bakhuizen van den Brink, R.C. Vegetables of the Dutch Indies, 3rd edn; Ascher & Co: Amsterdam, Netherland, 1980; p. 1016. [Google Scholar]
  26. Wetwitayaklung, P.; Phaechamud, T.; Limmatvapirat, C.; Keokitichai, S. The study of antioxidant activities of edible flower extracts. Acta Hortic. 2008, 786, 185–192. [Google Scholar] [CrossRef]
  27. Burdock, G.A. Fenaroli’s handbook of flavor ingredients. In CRC Press, 5th edn; Boca Raton, U.S., 2010; p. 1864. [Google Scholar]
  28. Toothman, C. It’s shocking, but you eat it. NPR 2009. [Google Scholar]
  29. Oliver-Bever, B.E.P. Medicinal plants in tropical West Africa. In Cambridge University Press; Cambridge, UK, 1986. [Google Scholar]
  30. Anon. The Wealth of India, A dictionary of Indian raw materials & industrial products. In Publications & Information Directorate; Chadha, Y.R., Ed.; New Delhi, India; Vol. 10, pp. Sp–W.
  31. Storey, C.; Salem, J.I. Lay use of Amazonian plants for the treatment of tuberculosis. Acta Amazonica 1997, 27, 175–182. [Google Scholar] [CrossRef]
  32. Jerônimo, L.B.; Santos, P.V.L.; Pinto, L.C.; Costa, J.S.; Andrade, E.H.A.; Setzer, W.N.; Silva, J.K.R.; Araújo, J.A.C.; Figueiredo, P.L.B. Acmella oleracea (L.) R.K. Jansen essential oils: Chemical composition, antioxidant, and cytotoxic activities. Biochem. Syst. Ecol. 2024, 112, 104775. [Google Scholar] [CrossRef]
  33. Spinozzi, E.; Pavela, R.; Bonacucina, G.; Perinelli, D.R.; Cespi, M.; Petrelli, R.; Cappellacci, L.; Fiorini, D.; Scortichini, S.; Garzoli, S.; et al. Spilanthol-rich essential oil obtained by microwave-assisted extraction from Acmella oleracea (L.) R.K. Jansen and its nanoemulsion: Insecticidal, cytotoxic and anti-inflammatory activities. Ind. Crops Prod. 2021, 172, 114027. [Google Scholar] [CrossRef]
  34. Prachayasittikul, S.; Suphapong, S.; Worachartcheewan, A.; Lawung, R.; Ruchirawat, S.; Prachayasittikul, V. Bioactive Metabolites from Spilanthes acmella Murr. Molecules 2009, 14, 850–867. [Google Scholar] [CrossRef]
  35. Bellumori, M.; Zonfrillo, B.; Maggini, V.; Bogani, P.; Gallo, E.; Firenzuoli, F.; Mulinacci, N.; Innocenti, M. Acmella oleracea (L.) R.K. Jansen: Alkylamides and phenolic compounds in aerial parts and roots of in vitro seedlings. J. Pharm. Biomed. Anal. 2022, 220, 114991. [Google Scholar] [CrossRef]
  36. Sharma, R.; Arumugam, N. N-alkylamides of Spilanthes (syn: Acmella): Structure, purification, characterization, biological activities and applications –a review. Future Foods 2021, 3, 100022. [Google Scholar] [CrossRef]
  37. Greger, H. Alkamides: a critical reconsideration of a multifunctional class of unsaturated fatty acid amides. Phytochem. Rev. 2016, 15, 729–770. [Google Scholar] [CrossRef]
  38. Boonen, J.; Bronselaer, A.; Nielandt, J.; Veryser, L.; Tré, G.D.; Spiegeleer, B.D. Alkamid database:Chemistry,occurrence and functionality of plant N-alkylamides. J. Ethnopharmacol. 2012, 142, 563–590. [Google Scholar] [CrossRef]
  39. Rios, M.Y. Natural Alkamides: Pharmacology, Chemistry and Distribution; Drug Discovery Research in Pharmacognosy Edited by Prof. Omboon Vallisuta. InTech, Shangai, China; 2012. p.108–144.
  40. Boonen, J.; Baert, B.; Burvenich, C.; Blondeel, P.; Saeger, S.D.; Spiegeleer, B.D. LC–MS profiling of N-alkylamides in Spilanthes acmella extract and the transmucosal behaviour of its main bio-active spilanthol. J. Pharm. Biomed. Anal. 2010, 53, 243–249. [Google Scholar] [CrossRef] [PubMed]
  41. Sharma, V.; Boonen, J.; Chauhan, N.; Thakur, M.; Spiegeleer, B.D.; Dixit, V.K. Spilanthes acmella ethanolic flower extract: LC–MS alkylamide profiling and its effects on sexual behavior in male rats. Phytomedicine 2011, 18, 1161–1169. [Google Scholar] [CrossRef] [PubMed]
  42. Kavallieratos, N.G.; Spinozzi, E.; Filintas, C.S.; Nika, E.P.; Skourti, A.; Panariti, A.M.E.; Ferrati, M.; Petrelli, R.; Ricciutelli, M.; Angeloni, S.; et al. Acmella oleracea extracts as green pesticides against eight arthropods attacking stored products. Environ. Sci. Pollut. Res. Int. 2023, 30, 94904–94927. [Google Scholar] [CrossRef] [PubMed]
  43. Abeysinghe, D.C.; Wijerathne, S.M.N.K.; Dharmadasa, R.M. Secondary Metabolites Contents and Antioxidant Capacities of Acmella Oleraceae Grown under Different Growing Systems. World J. Agric. Res. 2014, 2, 163–167. [Google Scholar] [CrossRef]
  44. Dias, A.M.A.; Santos, P.; Seabra, I.J.; Júnior, R.N.C.; Braga, M.E.M.; Sousa, H.C. Spilanthol from Spilanthes acmella flowers, leaves and stems obtained by selective supercritical carbon dioxide extraction. J. Supercrit. Fluids 2012, 61, 62–70. [Google Scholar] [CrossRef]
  45. Monroe, D.; Luo, R.; Tran, K.; Richards, K.M.; Barbosa, A.F.; Carvalho, M.G.; Sabaa-Srur, A.U.O.; Smith, R.E. LC-HRMS and NMR Analysis of Lyophilized Acmella oleracea Capitula, Leaves and Stems. Nat. Prod. J. 2016, 6, 116–125. [Google Scholar] [CrossRef]
  46. Stein, R.; Berger, M.; Cecco, B.S.; Mallmann, L.P.; Terraciano, P.B.; Driemeier, D.; Rodrigues, E.; Beys-da-Silva, W.O.; Konrath, E.L. Chymase inhibition: A key factor in the anti-inflammatory activity of ethanolic extracts and spilanthol isolated from Acmella oleracea. J. Ethnopharmacol. 2021, 270, 113610. [Google Scholar] [CrossRef]
  47. Savic, S.; Petrovic, S.; Savic, S.; Cekic, N. Identification and photostability of N-alkylamides from Acmella oleracea extract. J. Pharm. Biomed. Anal. 2021, 195, 113819. [Google Scholar] [CrossRef]
  48. Mbeunkui, F.; Grace, M.H.; Lategan, C.; Smith, P.J.; Raskin, I.; Lila, M.A. Isolation and identification of antiplasmodial N-alkylamides from Spilanthes acmella flowers using centrifugal partition chromatography and ESI-IT-TOF-MS. J. Chromatogr. B 2011, 879, 1886–1892. [Google Scholar] [CrossRef]
  49. Ferrara, V.; Zonfrillo, B.; Bellumori, M.; Innocenti, M.; Micheli, L.; Maggini, V.; Venturi, D.; Gallo, E.; Bogani, P.; Mannelli, L.D.C.; et al. Neuroprotective Potential of Acmella oleracea Aerial Parts and Root Extracts: The Role of Phenols and Alkylamides Against Neuropathic Pain. Nutrients 2025, 17, 2588. [Google Scholar] [CrossRef]
  50. Simas, N.K.; Dellamora, E.C.L.; Schripsema, J.; Lage, C.L.S.; Filho, A.M.O.; Wessjohann, L.; Porzel, A.; Kuster, R.M. Acetylenic 2-phenylethylamides and new isobutylamides from Acmella oleracea (L.) R. K. Jansen, a Brazilian spice with larvicidal activity on Aedes aegypti. Phytochem. Lett. 2013, 6, 67–72. [Google Scholar] [CrossRef]
  51. Ramsewak, R.S.; Erickson, A.J.; Nair, M.G. Bioactive N-isobutylamides from the ¯ower buds of Spilanthes acmella. Phytochem. 1999, 51, 729–732. [Google Scholar] [CrossRef] [PubMed]
  52. Greger, H.; Hofer, O.; Werner, A. New Amides from Spilanthes oleracea. Monatshefte ftir Chemie 1985, 116, 273–277. [Google Scholar] [CrossRef]
  53. Cheng, Y.; Liu, R.H.; Ho, M.; Wu, T.; Chen, C.; Lo, I.; Hou, M.; Yuan, S.; Wu, Y.; Chang, F. Alkylamides of Acmella oleracea. Molecules 2015, 20, 6970–6877. [Google Scholar] [CrossRef] [PubMed]
  54. Phrutivorapongkul, A.; Chaiwon, A.; Vejabhikul, S.; Netisingha, W.; Chansakaow, S. AN ANESTHETIC ALKAMIDE AND FIXED OIL FROM ACMELLA OLERACEA. J. Health Res. 2008, 22, 97–99. [Google Scholar]
  55. Nakatani, N.; Nagashima, M. Pungent Alkamides from Spilanthes acmella L. var. oleracea Clarke. Biosci. Biotech. Biochem. 1992, 56, 759–762. [Google Scholar] [CrossRef]
  56. Baruah, R.N.; Leclercq, P.A. Characterization of the Essential Oil from Flower Heads of Spilanthes acmella. J. Essent. Oil Res. 1993, 5, 693–695. [Google Scholar] [CrossRef]
  57. Lemos, T.L.G.; Pessoa, O.D.L.; Matos, F.J.A.; Alencar, J.W.; Craveiro, A.A. The Essential Oil of Spilanthes acmella Murr. J. Essent. Oil Res. 1991, 3, 369–370. [Google Scholar] [CrossRef]
  58. Kawaree, R.; Okonogi, S.; Chowwanapoonpohn, S.; Phutdhawong, W. Chemical composition and antioxidant evaluation of volatile oils from Thai medicinal plants. Acta Hortic. 2008, 786, 209–216. [Google Scholar] [CrossRef]
  59. Radulović, N.S.; Mladenović, M.Z.; Lima, C.S.; Müller, E.C.A.; Cost, E.V.M.; Martins, R.V.; Boylan, F. Amazon Rainforest Hidden Volatiles—Part I: Unveiling New Compounds from Acmella oleracea (L.) R.K. Jansen Essential Oil. Plants 2024, 13, 1690. [Google Scholar] [CrossRef]
  60. Krishnaswamy, N.R.; Prasanna, S. α- and β-amyrin esters and sitosterol glucoside from Spilanthes acmella. Phytochem. 1975, 14, 1666–1667. [Google Scholar] [CrossRef]
  61. Nascimento, L.E.S.; Arriola, N.D.A.; Silva, L.A.L.; Faqueti, L.G.; Sandjo, L.P.; Araújo, C.E.S.; Biavatti, M.W.; Barcelos-Oliveira, J.L.; Amboni, R.D.M.C. Phytochemical profile of different anatomical parts of jambu (Acmella oleracea (L.) R.K. Jansen): A comparison between hydroponic and conventional cultivation using PCA and cluster analysis. Food Chem. 2020, 332, 127393. [Google Scholar] [CrossRef] [PubMed]
  62. Jirovetz, L.; Buchbauer, G.; Wobus, A. Essential Oil Analysis of Spilanthes acmella Murr. Fresh Plants from Southern India. J. Essent. Oil Res. 2005, 17, 429–431. [Google Scholar] [CrossRef]
  63. Satao, N.T.; Mahindrakar, K.V.; Rathod, V.K. Extraction of phenolics from Spilanthes Acmella plant: Kinetic studies using Peleg’s model. J. Indian Chem. Soc. 2025, 102, 101634. [Google Scholar] [CrossRef]
  64. Payum, T. PHYTOCONSTITUENTS OF SPILANTHES OLERACEA LINN. SHOOT: A MEDICINAL FOOD HERB USED AMONG TRIBAL PEOPLE OF ARUNCHAL PRADESH, INDIA. IJPSR 2017, 8, 4381–4387. [Google Scholar]
  65. Nabi, N.G.; Shrivastava, M. Estimation of Total Flavonoids and Antioxidant Activity of Spilanthes acmella Leaves. UK J. Pharm. Biosci. 2016, 4, 29–34. [Google Scholar]
  66. Perveen, S. Introductory Chapter: Terpenes and Terpenoids. IntechOpen 2018, 79683. [Google Scholar]
  67. Ludwiczuk, A.; Skalicka-Woźniak, K.; Georgiev, M.I. Terpenoids, Chapter 11; Elsevier Inc, 2017. [Google Scholar]
  68. Hussein, R.; El-Anssary, A. Plants Secondary Metabolites: The Key Drivers of the Pharmacological Actions of Medicinal Plants; IntechOpen., 2019. [Google Scholar]
  69. Dhifi, W.; Bellili, S.; Jazi, S.; Bahloul, N.; Mnif, W. Essential Oils’ Chemical Characterization and Investigation of Some Biological Activities: A Critical Review. Medicines 2016, 3, 25. [Google Scholar] [CrossRef]
  70. Pheko-Ofitlhile, T.; Makhzoum, A. Impact of hydrodistillation and steam distillation on the yield and chemical composition of essential oils and their comparison with modern isolation techniques. J. Essent. Oil Res. 2024, 36, 105–115. [Google Scholar] [CrossRef]
  71. Boutekedjiret, C.; Bentahar, F.; Belabbes, R.; Bessiere, J.M. Extraction of rosemary essential oil by steam distillation and hydrodistillation. Flavour Fragr. J. 2003, 18, 481–484. [Google Scholar] [CrossRef]
  72. Shiferaw, Y.; Kassahun, A.; Tedla, A.; Feleke, G.; Abebe, A.A. Investigation of Essential Oil Composition Variation with Age of Eucalyptus Globulus Growing in Ethiopia. NPCR 2019, 7, 360. [Google Scholar] [CrossRef]
  73. Tongnuanchan, P.; Benjakul, S. Essential Oils: Extraction, Bioactivities, and Their Uses for Food Preservation. J. Food Sci. 2014, 79, R1231–R1249. [Google Scholar] [CrossRef] [PubMed]
  74. Gani, M.A; Sharma, M.S. Introductory Chapter: Phenolic compounds; IntechOpen, 2021. [Google Scholar]
  75. Harborne, J.B. Secondary plant products: encyclopedia of plant physiology. Phytochem. 1980, 8, 2803–2804. [Google Scholar] [CrossRef]
  76. Scalbert, A.; Manach, C.; Morand, C.; Rémésy, C.; Jiménez, L. Dietary polyphenols and the prevention of diseases. Critical reviews in food science and nutrition. Crit. Rev. Food Sci. Nutr. 2005, 45, 287–306. [Google Scholar]
  77. Satao, N.T.; Mahindrakar, K.V.; Rathod, V.K. Extraction of phenolics from Spilanthes Acmella plant: Kinetic studies using Peleg’s model. J. Indian Chem. Soc. 2025, 102, 101634. [Google Scholar]
  78. Tsao, R. Chemistry and Biochemistry of Dietary Polyphenols. Nutrients 2010, 2, 1231–1246. [Google Scholar] [CrossRef]
  79. Orsavova, J.; Misurcova, L.; Ambrozova, J.V.; Vicha, R.; Mlcek, J. Fatty Acids Composition of Vegetable Oils and Its Contribution to Dietary Energy Intake and Dependence of Cardiovascular Mortality on Dietary Intake of Fatty Acids. Int. J. Mol. Sci. 2015, 16, 12871–12890. [Google Scholar] [CrossRef]
  80. Ojha, P.K.; Poudel, D.K.; Rokaya, A.; Maharjan, S.; Timsina, S.; Poudel, A.; Satyal, R.; Satyal, P.; Setzer, W.N. Chemical Compositions and Essential Fatty Acid Analysis of Selected Vegetable Oils and Fats. Compounds 2024, 4, 37–70. [Google Scholar] [CrossRef]
  81. Nathan, C.; Ding, A. Nonresolving Inflammation. Cell 2010, 140, 871–882. [Google Scholar] [CrossRef]
  82. Kim, K.H.; Kim, E.J.; Kwun, M.J.; Lee, J.Y.; Bach, T.T.; Eum, S.M.; Choi, J.Y.; Cho, S.; Kim, S.J.; Jeong, S.; Joo, M. Suppression of lung inflammation by the methanol extract of Spilanthes acmella Murray is related to differential regulation of NF-κB and Nrf2. J. Ethnopharmacol. 2018, 217, 89–97. [Google Scholar] [CrossRef]
  83. Wu, L.; Fan, N.; Lin, M.; Chu, I.; Huang, S.; Hu, C.; Han, S. Anti-inflammatory Effect of Spilanthol from Spilanthes acmella on Murine Macrophage by Down-Regulating LPS-Induced Inflammatory Mediators. J. Agric. Food Chem. 2008, 56, 2341–2349. [Google Scholar] [CrossRef] [PubMed]
  84. Huang, W.; Huang, C.; Hu, S.; Peng, H.; Wu, S. Topical Spilanthol Inhibits MAPK Signaling and Ameliorates Allergic Inflammation in DNCB-Induced Atopic Dermatitis in Mice. Int. J. Mol. Sci. 2019, 20, 2490. [Google Scholar] [CrossRef] [PubMed]
  85. Wongsawatkul, O.; Prachayasittikul, S.; Isarankura-Na-Ayudhya, C.; Satayavivad, J.; Ruchirawat, S.; Prachayasitticul, V. Vasorelaxant and Antioxidant Activities of Spilanthes acmella Murr. Int. J. Mol. Sci. 2008, 9, 2724–2744. [Google Scholar] [CrossRef] [PubMed]
  86. Thakur, S.; Sagar, A.; Prakash, V. STUDIES ON ANTIBACTERIAL AND ANTIOXIDANT ACTIVITY OF DIFFERENT EXTRACTS OF SPILANTHES ACMELLA L. Plant Arch. 2019, 19, 1711–1717. [Google Scholar]
  87. Fajardo, J.B.; Vianna, M.H.; Polo, A.B.; Comitre, M.R.C.; Oliveira, D.A.; Ferreira, T.G.; Lemos, A.S.O.; Souza, T.F.; Campos, L.M.; Paula, P.L.; et al. Insights into the bioactive potential of the Amazonian species Acmella oleracea leaves extract: A focus on wound healing applications. J. Ethnopharmacol. 2025, 337, 118866. [Google Scholar]
  88. Gay, N.H.; Phopin, K.; Suwanjang, W.; Songtawee, N.; Ruankham, W.; Wongchltrat, P.; Prachayasitticul, S.; Prachayasitticul, V. Neuroprotective Effects of Phenolic and Carboxylic Acids on Oxidative Stress-Induced Toxicity in Human Neuroblastoma SH-SY5Y Cells. Neurochem. Res. 2018, 43, 619–636. [Google Scholar]
  89. Dallazen, J.L.; Maria-Ferreira, D.; Luz, B.B.; Nascimento, A.M.; Cipriani, T.R.; Souza, L.M.; Glugoski, L.P.; Silva, B.J.G.; Geppetti, P.; Werner, M.F.P. Distinct mechanisms underlying local antinociceptive and pronociceptive effects of natural alkylamides from Acmella oleracea compared to synthetic isobutylalkyl amide. Fitoterapia 2018, 131, 225–235. [Google Scholar] [CrossRef]
  90. Yien, R.M.K.; Gomes, A.C.C.; Fiorot, R.G.; Miranda, A.L.P.; Neves, G.A.; Andrade, B.S.; Costa, F.N.; Tributino, J.L.M.; Simas, N.K. Alkylamides from Acmella oleracea: antinociceptive effect and molecular docking with cannabinoid and TRPV1 receptors. Nat. Prod. Res. 2023, 37, 3136–3144. [Google Scholar]
  91. Chakraborty, A.; Devi, B.R.K.; Sanjebam, R.; Khumbong, S.; Thokchom, I.S. Preliminary studies on local anesthetic and antipyretic activities of Spilanthes acmella Murr. in experimental animal models. Indian J. Pharmacol. 2010, 42, 277–279. [Google Scholar] [CrossRef]
  92. Barbas, L.A.; Stringhetta, G.R.; Garcia, L.O.; Figueiredo, M.R.C.; Sampaio, L.A. Jambu, Spilanthes acmella as a novel anaesthetic for juvenile tambaqui, Colossoma macropomum: Secondary stress responses during recovery. Aquaculture 2016, 456, 70–75. [Google Scholar] [CrossRef]
  93. Castro-Ruiz, J.E.; Rojas-Molina, A.; Luna-Vázquez, F.J.; Rivero-Cruz, F.; García-Gasca, T.; Ibarra-Alvarado, C. Affinin (Spilanthol), Isolated from Heliopsis longipes, Induces Vasodilation via Activation of Gasotransmitters and Prostacyclin Signaling Pathways. Int. J. Mol. Sci. 2017, 18, 218. [Google Scholar] [CrossRef]
  94. Silva, A.P.S.; Pires, F.C.S.; Ferreira, M.C.R.; Siqueira, L.M.M.; Menezes, E.G.O.; Carvalho, M.E.F.; Nascimento, L.A.S.; Santos, A.S.; Hamoy, A.O.; Hamoy, M.; Carvalho Junior, RN. Antiarrhythmic Effects of Supercritical Extract of Acmella oleracea in Rats: Electrophysiological Evidence and Cardioprotective Potential. Plants 2025, 14, 2848. [Google Scholar] [CrossRef]
  95. Nascimento, A.M; Souza, L.M.; Baggio, C.H.; Werner, M.F.P.; Maria-Ferreira, D.; Silva, L.M.; Sassaki, G.L.; Gorin, P.A.J.; Iacomini, M.; Ciprinai, T.R. Gastroprotective effect and structure of a rhamnogalacturonan from Acmella oleracea. Phytochem. 2013, 85, 137–142. [Google Scholar] [CrossRef]
Figure 1. Morphological image of A. oleracea. (A) Aerial part, (B) Flower with pedicel, (C) Leaf with petiole. The plant images in this article are from the open resources of Plant Photo Bank of China, PPBC).
Figure 1. Morphological image of A. oleracea. (A) Aerial part, (B) Flower with pedicel, (C) Leaf with petiole. The plant images in this article are from the open resources of Plant Photo Bank of China, PPBC).
Preprints 194608 g001
Figure 2. General geographical distribution of A. oleracea in the world (powo.science.kew.org).
Figure 2. General geographical distribution of A. oleracea in the world (powo.science.kew.org).
Preprints 194608 g002
Figure 5. Structures of phenolic compounds in A. oleracea.
Figure 5. Structures of phenolic compounds in A. oleracea.
Preprints 194608 g005
Table 1. Taxonomy of A. oleracea.
Table 1. Taxonomy of A. oleracea.
Taxa Name
Kingdom Plantae
Subkingdom Tracheobiont
Phylum Tracheophyta
Division Magnoliophyta
Superdivision Spermatophyte
Class Magnoliopsida
Subclass Asteridae
Order Asterales
Family Asteraceae
Subfamily Mimosoideae
Genus Acmella
Species Oleracea
Table 2. Traditional application of A. oleracea.
Table 2. Traditional application of A. oleracea.
Part Traditional uses (country) Ref.
Medicinal
F Toothache (Many countries in America, Asia and Africa such as Peru, Brazil, India, etc.), Bleeding, Stammering, Xerostomia (India) [12,13,17,29,30]
F&L Tuberculosis (Brazil), Leucorrhoea (Bangladesh) [18,19,21,23,31]
WP Poisonous sting (Bangladesh), Rheumatism (India, Cameroon), Snakebite (Cameroon), Stomatitis (Indonesia), Urolithiasis, Digestive problem, Scurvy,
R Throat problem (India), Constipation [15,21]
Culinary
F Used in curries (Taiwan), Spice (Japan), Additives in drinks, cocktails [24,26,27,28]
L Raw or vegetable (India, Brazil), Pungent flavoring for salads (U.S.), Served raw in ‘lalab’ with other vegetables and eaten with a sambal (chilli sauce) (Indonesia) [22,23,24,25]
F: Flower; L: Leave; WP: Whole plant.
Table 5. Summary of the information on preparation of phenolic compounds from A. oleracea.
Table 5. Summary of the information on preparation of phenolic compounds from A. oleracea.
No. Part (origin) Solvent Extraction Analysis Contents Remarks Ref.
1 F (India) Various factors (solvent, solvent ratio, temperature) Soxhlet Colorimetric method Order of total phenolic content (mg GAE/g DM)
- Solvent: MeOH>Water>Acetone>EtOH>n-BuOH
- Solvent ratio: 50>30>40>20>10
- Temperature: 50>60>40>30
- Agitation speed: 500>400>300>200>100
- pH: 5>4>6>7>8
- Comprehensive kinetic study of various factors influencing the extraction of total phenolic contents (solvent, solvent ratio, temperature, agitation speed, pH) [62]
2 F, L, S (Sri lanka) MeOH (1:3) Soxhlet Colorimetric method Total phenolic content (mg GAE/g, DM)
- 5.34 (F), 7.59 (L), 1.65 (S)
- Comparison of active metabolites in different parts of the plant [7]
3 F, L, S (India) 80% EtOH (1:20, w:v, 60 °C) Sonication Colorimetric method Total phenolic content (mg GAE/g, DW)
- FG: 1.98 (F), 3.19 (L), 1.37 (S)
- HG: 1.70 (F), 1.95 (L), 0.71 (S)
Total flavonoid content (mg RE/g, DW)
- FG: 5.91 (F), 11.45 (L), 3.80 (S)
- HG: 7.98 (F), 9.10 (L), 3.38 (S)
- Comprehensive comparison of active metabolites in different parts of the plant and different growing conditions
[60]
4 L (Sri lanka) 80% MeOH (1:50, w:v, 6 °C) Maceration Colorimetric method Total phenolic content (mg GAE/g, DW)
- 10.99 (FG), 11.45 (HG), 9.91 (CC)
Total flavonoid content (mg RE/g, DW)
- 11.33 (FG), 12.33 (HG), 7.38 (CC)
- Comparison of active metabolites under different growing systems
- Total antioxidant capacity was proportional to total phenolic and flavonoid content
[42]
5 AP, R (in vitro seedling) 80% EtOH (1:20, w:v, 60 °C) Sonication HPLC-DAD-MS Amount of total phenols (mg/g DE)
- AP: 8.68
- R: 14.15
Order of amount of major phenols
- AP: 53, 51, 54, 49, 50, 55, 56
- R: 51(50% of total phenol), 50, 49, 56
- Samples were prepared after defatting by n-hexane [48]
F: Flower; L: Leave; S: Stem, AP: Aerial part; R: Root; DM: Dry matter; DW: Dry weight; GAE: gallic acid equivalent; RE: rutin equivalent; FG: Field grown; HG: Hydroponically grown; CC: Callus culture; 4.4. Others.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2026 MDPI (Basel, Switzerland) unless otherwise stated